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National Gay Men’s HIV/AIDS 
Awareness Day — September 27, 2010
National Gay Men’s HIV/AIDS Awareness Day is 
observed each year on September 27 to focus on the 
disproportionate effects of the human immunodeficiency 
virus (HIV) epidemic on gay, bisexual, and other men who 
have sex with men (MSM). In 2007, the estimated HIV 
diagnosis rate among MSM was 692 per 100,000, which 
was 44 to 86 times the rate for other men and 40 to 77 
times the rate for women (1).
Although MSM represent approximately 2% of the 
U.S. population (1), in 2006 they accounted for 57% of 
all new HIV infections (2). From 2005 to 2008, estimated 
diagnoses of HIV infection increased approximately 17% 
among MSM in 37 states (3). In 2008, black MSM had the 
highest estimated number of diagnoses of HIV infection, 
followed by white and Hispanic MSM (3). In recent years, 
new HIV diagnoses have increased significantly among 
young black MSM (4).
CDC supports a range of efforts to reduce HIV infec-
tion among MSM. These include HIV prevention services 
that aim to reduce the risk for acquiring and transmitting 
HIV and to increase the linkage of infected MSM to 
treatment. Additional information about these efforts and 
National Gay Men’s HIV/AIDS Awareness Day activities 
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Prevalence and Awareness 
of HIV Infection Among Men 
Who Have Sex With Men — 
21 Cities, United States, 2008
Men who have sex with men (MSM) are at increased risk 
for infection with human immunodeficiency virus (HIV). In 
2006, 57% of new HIV infections in the United States occurred 
among MSM (1). To estimate and monitor risk behaviors, 
CDC’s National HIV Behavioral Surveillance system (NHBS) 
collects data from metropolitan statistical areas (MSAs) using 
an anonymous cross-sectional interview of men at venues where 
MSM congregate, such as bars, clubs, and social organizations. 
This report summarizes NHBS data from 2008, which indicated 
that, of 8,153 MSM interviewed and tested in the 21 MSAs 
participating in NHBS that year, HIV prevalence was 19%, 
with non-Hispanic blacks having the highest prevalence (28%), 
followed by Hispanics (18%), non-Hispanic whites (16%), and 
persons who were multiracial or of other race (17%). Of those 
who were infected, 44% were unaware of their infection. Men 
who know their current HIV infection status can be linked to 
appropriate medical care and prevention services. Once linked 
to prevention services, men can learn ways to avoid transmitting 
the virus to others. Young MSM (aged 18–29 years) (63%) and 
minority MSM (other than non-Hispanic white) (54%) were 
more likely to be unaware of their HIV infection. Efforts to 
ensure at least annual HIV testing for MSM should be strength-
ened, and HIV testing and prevention programs should increase 
their efforts to reach young and minority MSM.
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(3). Venues and the corresponding day/time periods 
(VDTs) were chosen randomly each month. Staff 
members then systematically approached men at the 
venues (2). Men eligible for being interviewed were 
aged ≥18 years, residents of the MSAs, and able to 
complete the interview in English or Spanish. After 
participants gave informed consent, trained inter-
viewers administered a standardized, anonymous 
questionnaire using a handheld computer. The inter-
view consisted of questions about sex, drug use, HIV 
testing behaviors, and use of HIV prevention services. 
All respondents were offered anonymous HIV test-
ing, regardless of self-reported HIV infection status, 
given the opportunity to receive their test results, and 
anonymously referred to care when appropriate. HIV 
testing was performed by collecting blood or oral 
specimens for either Western blot (WB) or immu-
nofluorescence assay (IFA) confirmatory testing in a 
laboratory or rapid testing at venues using Food and 
Drug Administration (FDA)–approved tests for use 
in nonlaboratory settings. A nonreactive rapid test 
was considered a definitive negative result; reactive 
(preliminary positive) rapid test results were consid-
ered definitive positive only when confirmed by WB 
NHBS is a behavioral surveillance system used 
to monitor prevalence and trends in 1) HIV-related 
risk behaviors, 2) HIV testing, and 3) use of HIV 
prevention services among populations at high risk 
for acquiring HIV, including MSM, injection-drug 
users, and heterosexuals at increased risk for HIV 
infection. Data are collected in annual cycles from 
one risk group per year so that each group is sur-
veyed once every 3 years. The first cycle of NHBS 
(among MSM) was conducted in 15 MSAs during 
2004–2005; behavioral surveys were conducted in 
10 MSAs, and HIV testing in conjunction with the 
behavioral survey was conducted in five MSAs (2). 
In 2008, NHBS staff members in 21 MSAs collected 
cross-sectional behavioral risk data and conducted 
HIV testing among MSM. MSAs were selected based 
on high prevalence of acquired immunodeficiency 
syndrome (AIDS); the 21 MSAs included approxi-
mately 60% of all prevalent urban U.S. AIDS cases 
in 2006. MSM were sampled using venue-based, 
time-space sampling methods. Health department 
staff members first identified appropriate venues (e.g., 
bars, clubs, organizations, and street locations) and 
days and times when men frequented those venues 
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or IFA. MSM unaware of their HIV infection were 
defined as those who tested HIV-positive at the time 
of the interview but reported that the result of their 
most recent HIV test was negative, indeterminate, or 
unknown, or that they had never been tested. Men 
were compensated both for their time participating 
in the interview and for taking an HIV test.
In 2008, a total of 28,468 men were approached, 
and 12,325 were screened for participation in NHBS 
at 626 venues in 21 MSAs. Of men who were 
screened, 11,074 (90%) were eligible for the survey. 
Men were excluded from analysis if they did not con-
sent to and complete both the survey and the HIV test 
(n = 1,558), did not report sex with a man during the 
preceding 12 months (n = 1,744), had an indetermi-
nate HIV test result (n = 85), or reported being HIV-
positive but had a negative NHBS HIV test result 
(n = 60). These criteria were not mutually exclusive; 
a total of 2,921 men were excluded from analysis. 
Of eligible men, 8,153 (74%) were MSM who met 
criteria for inclusion in this analysis. The median age 
of the MSM in this report was 32 years (range: 18–85 
years); 44% were non-Hispanic white, 25% Hispanic, 
23% non-Hispanic black, 2% Asian, 0.8% Native 
Hawaiian/Pacific Islander, 0.6% American Indian/
Alaska Native, and 4% multiracial or other. Thirty-
seven percent had a college education or higher, and 
30% reported an annual household income <$20,000. 
Sixty-seven percent of men reported a household size 
of one. The majority had health insurance (66%) and 
had visited a health-care provider during the preceding 
year (76%) (Table 1).
Among the 8,153 MSM tested, 1,562 (19%) 
tested positive for HIV (range by MSA: 6%–38%). 
HIV prevalence was 28% among blacks, 18% among 
Hispanics, and 16% among whites. HIV prevalence 
increased with increasing age and decreased with 
increasing education and income (Table 1).
Of the 1,562 HIV-infected MSM, 680 (44%) 
were unaware of their infection. The proportion who 
were unaware of their infection was higher among 
younger than older MSM (Table 1). The proportion 
unaware was highest among blacks (59%), lowest 
among whites (26%), and decreased with increasing 
education and income. Higher proportions of MSM 
with no health insurance and those who had not vis-
ited a health-care provider during the preceding year 
were unaware of their infection (Table 1). Fifty-five 
percent of MSM unaware of their infection had not 
been tested during the preceding 12 months.
The HIV prevalence by age group and race/
ethnicity for MSM aged <30 years was highest among 
black MSM in each age group. The majority of young 
black and Hispanic MSM in each age group were 
unaware of their HIV infection (Table 2).
For comparison with a previous NHBS report of 
MSM HIV prevalence during 2004–2005, which 
indicated an HIV prevalence of 26% among MSM 
and an infection unawareness rate of 48% (4), five 
MSAs (Baltimore, Maryland; Los Angeles, California; 
Miami, Florida; New York, New York; and San 
Francisco, California) were analyzed separately in 
the analysis of 2008 data. Results indicated that the 
overall HIV prevalence was 27%, and 48% of HIV-
positive participants were unaware of their infection. 
HIV prevalence among blacks was 40%; 63% were 
unaware of their infection. These prevalence rates were 
similar to those from 2004–2005 NHBS data*; the 
proportion of MSM unaware of their infection did 
not increase (Table 3).†
* In New York, HIV prevalence rose between the two periods, but this 
was primarily caused by an increase in the proportion of participants 
who were black, Hispanic, or aged ≥40 years.
† Original report was based on preliminary data. Percentages in this 
report reflect unpublished analyses of final data.
What is already known on this topic?
The greatest number of human immunodeficiency 
virus (HIV) infections in the United States occur 
among men who have sex with men (MSM).
What is added by this report?
Data from a convenience sample of MSM in 21 U.S. 
cities indicated an HIV prevalence of 19% in 2008; 
44% of HIV-infected MSM were unaware of their HIV 
infection, and the highest HIV prevalence and infec-
tion unawareness were among young and minority 
MSM. More than half (55%) of MSM unaware of their 
infection reported not having an HIV test during the 
preceding 12 months.
What are the implications for public health practice?
Increased efforts to educate MSM and health-care 
providers about HIV testing guidelines and to reduce 
barriers to HIV testing for MSM are necessary; MSM 
remain a key target for HIV testing and prevention 
programs.
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TABLE 1. Prevalence of human immunodeficiency virus (HIV) infection and proportion unaware of HIV infection among men 
who have sex with men, by selected characteristics — National HIV Behavioral Surveillance System, 21 U.S. cities, 2008
Characteristic Total no. tested
HIV prevalence Unaware of HIV Infection
No. (%) (95% CI*) No. (%) (95% CI)
Age group (yrs)
 18–19 423 28 (7) (4–9) 21 (75) (55–89)
 20–24 1,466 170 (12) (10–13) 115 (68) (61–75)
 25–29 1,529 223 (15) (13–17) 128 (57) (51–64)
 30–39 2,231 470 (21) (19–23) 214 (46) (41–50)
 40–49 1,712 474 (28) (26–30) 164 (35) (30–39)
 ≥50 792 197 (25) (22–28) 38 (19) (14–26)
Race/Ethnicity†
American Indian/Alaska Native 45 8 (18) (8–32) —§ —§ —§
Asian 185 14 (8) (4–12) 6 (43) (18–71)
Black, non-Hispanic 1,895 539 (28) (26–31) 318 (59) (55–63)
Hispanic 2,045 358 (18) (16–19) 163 (46) (40–51)
Native Hawaiian/Pacific Islander 62 11 (18) (9–30) 5 (45) (17–77)
White, non-Hispanic 3,580 560 (16) (15–17) 143 (26) (22–29)
Other¶ 336 72 (21) (17–26) 42 (58) (46–70)
Education
Less than high school diploma 526 132 (25) (21–29) 68 (52) (43–60)
High school diploma or equivalent 1,904 446 (23) (22–25) 236 (53) (48–58)
Some college or technical college 2,714 565 (21) (19–22) 230 (41) (37–45)
College or higher education 3,009 419 (14) (13–15) 146 (35) (30–40)
Annual household income†
 ≤$19,999 2,416 639 (26) (25–28) 305 (48) (44–52)
 $20,000–$39,999 2,084 391 (19) (16–20) 182 (47) (42–52)
 $40,000–$74,999 1,986 302 (15) (14–17) 117 (39) (33–45)
 ≥$75,000 1,557 213 (14) (12–16) 64 (30) (24–37)
Sexual identity†
Heterosexual 96 8 (8) (4–16) 5 (63) (25–92)
Bisexual 1,485 273 (18) (16–20) 173 (63) (57–69)
Homosexual 6,562 1,279 (19) (19–21) 501 (39) (37–42)
Health insurance†
No 2,722 513 (19) (17–20) 290 (57) (52–61)
Yes 5,305 1,019 (19) (18–20) 379 (37) (34–40)
Visited health-care provider in past year†
No 1,940 228 (12) (10–13) 185 (81) (75–86)
Yes 6,210 1,334 (21) (21–23) 495 (37) (35–40)
Most recent HIV test†
Never 745 106 (14) (12–17) 106 (100) (97–100)
>12 months ago 2,632 843 (32) (30–34) 262 (31) (28–34)
≤12 months ago 4,752 605 (13) (12–14) 306 (51) (47–55)
Metropolitan statistical area
Atlanta, Georgia 343 22 (6) (4–10) 12 (55) (32–76)
Baltimore, Maryland 447 169 (38) (33–43) 124 (73) (66–80)
Boston, Massachusetts 198 24 (12) (8–18) 7 (29) (13–51)
Chicago, Illinois 516 93 (18) (15–22) 49 (53) (42–63)
Dallas, Texas 461 119 (26) (22–30) 64 (54) (44–63)
Denver, Colorado 449 70 (16) (12–19) 14 (20) (11–31)
Detroit, Michigan 312 44 (14) (10–19) 31 (70) (55–83)
Houston, Texas 436 113 (26) (22–30) 26 (23) (16–32)
Los Angeles, California 478 89 (19) (15–22) 29 (33) (23–43)
Miami, Florida 526 133 (25) (22–29) 60 (45) (37–54)
Nassau-Suffolk, New York 242 19 (8) (5–12) 5 (26) (9–51)
New Orleans, Louisiana 354 76 (21) (17–26) 20 (26) (17–38)
New York, New York 462 132 (29) (25–33) 69 (52) (43–61)
Newark, New Jersey 80 15 (19) (11–29) —§ —§ —§
Philadelphia, Pennsylvania 440 48 (11) (8–14) 34 (71) (56–83)
San Diego, California 490 87 (18) (15–21) 35 (40) (30–51)
San Francisco, California 474 111 (23) (20–28) 21 (19) (12–28)
San Juan, Puerto Rico 313 36 (12) (8–16) 26 (72) (55–86)
Saint Louis, Missouri 306 42 (14) (10–18) 14 (33) (20–50)
Seattle, Washington 352 52 (15) (11–19) 8 (15) (7–28)
Washington, DC 474 68 (14) (11–18) 28 (41) (29–54)
Total 8,153 1,562 (19) (18–20) 680 (44) (41–46)
* Confidence interval. Calculated using the Clopper-Pearson method.
† Numbers might not add to total because of missing data.
§ Suppressed because of small cell size (fewer than five).
¶ Includes persons who indicated multiple races or other race. 
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Reported by
A Smith, MPH, I Miles, ScD, B Le, MD, T Finlayson, 
PhD, A Oster, MD, E DiNenno, PhD, Div of HIV/
AIDS Prevention, National Center for HIV/AIDS, Viral 
Hepatitis, STD, and TB Prevention, CDC.
Editorial Note
The findings from this analysis corroborate other 
surveillance data showing that HIV prevalence 
among MSM remains high, many HIV-infected 
MSM are unaware that they are infected with HIV, 
and minority MSM are disproportionately affected 
by HIV (5–6). Because MSM represent the only 
group with increasing HIV incidence and comprise 
the largest proportion of new infections (1), it is 
critical to target resources and prevention strategies to 
MSM. The National HIV/AIDS Strategy§ emphasizes 
the importance of improving the impact of HIV 
prevention efforts for MSM. The NHBS data also 
underscore the specific need for increased HIV testing 
efforts for all MSM, especially minority MSM; CDC 
recently broadened its expanded HIV testing initiative 
to reach more MSM.¶
CDC currently recommends that sexually active 
MSM get tested for HIV at least once per year (7). 
NHBS data demonstrate that 55% of MSM who 
were unaware of their HIV infection had not had 
an HIV test during the preceding 12 months. This 
finding suggests that increased efforts to educate 
MSM and health-care providers about HIV testing 
guidelines and to reduce barriers to HIV testing for 
TABLE 2. Prevalence of human immunodeficiency virus (HIV) infection and 
proportion unaware of HIV infection among young men who have sex with 
men, by age group and race/ethnicity — National HIV Behavioral Surveillance 




HIV prevalence Unaware of HIV Infection
No. (%) (95% CI*) No. (%) (95% CI)
18–19 yrs
Black, non-Hispanic 193 17 (9) (5–14) 12 (71) (44–90)
Hispanic 137 5 (4) (1–8) 4 (80) (28–100)
White, non-Hispanic 63 —† —† —† —† —† —†
20–24 yrs
Black, non-Hispanic 482 95 (20) (16–24) 66 (69) (59–79)
Hispanic 415 33 (8) (6–11) 24 (73) (55–87)
White, non-Hispanic 440 29 (7) (5–9) 16 (55) (36–74)
25–29 yrs
Black, non-Hispanic 346 105 (30) (26–36) 76 (72) (63–81)
Hispanic 412 50 (12) (9–16) 27 (54) (39–68)
White, non-Hispanic 607 46 (8) (6–10) 14 (30) (18–46)
Total 3,098 382 (12) (11–14) 241 (63) (58–68)
* Confidence interval. Calculated using the Clopper-Pearson method.
† Suppressed because of small cell size (fewer than five).
TABLE 3. Prevalence of human immunodeficiency virus (HIV) infection and proportion unaware of HIV infection among men who have sex 
with men, by age group and race/ethnicity — National HIV Behavioral Surveillance System, five U.S. cities, June 2004–April 2005 and 2008
Characteristic
June 2004–April 2005 2008
Total no. 
tested
HIV prevalence Unaware of HIV Infection
Total no. 
tested
HIV prevalence Unaware of HIV Infection
No. (%) (95% CI*) No. (%) (95% CI) No. (%) (95% CI) No. (%) (95% CI)
Age group (yrs)
 18–19 85 12 (14) (8–23) 9 (75) (43–95) 119 13 (11) (6–18) 9 (69) (39–91)
 20–24 327 48 (15) (11–19) 39 (81) (67–91) 406 63 (16) (12–19) 53 (84) (73–92)
 25–29 306 53 (17) (13–22) 38 (72) (58–83) 432 87 (20) (17–24) 57 (66) (55–75)
 30–39 589 172 (29) (26–33) 84 (49) (41–57) 676 192 (28) (25–32) 93 (48) (41–56)
 40–49 360 138 (38) (33–44) 39 (28) (21–37) 521 185 (36) (31–40) 69 (37) (30–45)
 ≥50 99 30 (30) (22–40) 9 (30) (15–49) 233 94 (40) (34–47) 22 (23) (15–33)
Race/Ethnicity†
Black, non-Hispanic 441 203 (46) (41–51) 136 (67) (60–73) 625 252 (40) (36–44) 160 (63) (57–69)
Hispanic 464 82 (18) (14–22) 41 (50) (39–61) 846 195 (23) (20–26) 87 (45) (38–52)
White, non-Hispanic 616 126 (21) (17–24) 23 (18) (12–26) 708 142 (20) (17–23) 27 (19) (13–26)
Other§ 229 39 (17) (12–23) 18 (46) (30–63) 206 45 (22) (16–28) 29 (64) (49–78)
Metropolitan statistical area
Baltimore, Maryland 468 182 (39) (34–44) 112 (62) (54–69) 447 169 (38) (33–43) 124 (73) (66–80)
Los Angeles, California 376 73 (19) (16–24) 31 (43) (31–55) 478 89 (19) (15–22) 29 (33) (23–43)
Miami, Florida 225 49 (22) (17–28) 24 (49) (34–64) 526 133 (25) (22–29) 60 (45) (37–54)
New York, New York 336 62 (19) (14–23) 32 (52) (39–65) 462 132 (29) (25–33) 69 (52) (43–61)
San Francisco, California 361 87 (24) (20–29) 19 (22) (14–32) 474 111 (23) (20–28) 21 (19) (12–28)
Total 1,766 453 (26) (24–28) 218 (48) (43–53) 2,387 634 (27) (25–28) 303 (48) (44–52)
* Confidence interval. Calculated using the Clopper-Pearson method.
† Numbers might not add to total because of missing data.
§ Because of small sample sizes, category includes American Indian/Alaska Native, Asian, Native Hawaiian/Pacific Islander, and persons who indicated multiple races 
or other race.
§ Additional information available at http://www.whitehouse.gov/
administration/eop/onap.
¶ Additional information available at http://www.cdc.gov/hiv/topics/
funding/ps10-10138/index.htm.
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MSM are necessary. Also, because 45% of MSM who 
were unaware of their infection were tested within the 
previous 12 months, shorter intervals for testing some 
MSM might be warranted and should be considered 
in future recommendations.
This analysis shows racial and economic disparities 
in both HIV prevalence and awareness of HIV infec-
tion. Racial disparities were observed in the youngest 
age group (18–19 years) and increased with age. CDC 
is working to decrease these racial disparities and cur-
rently funds HIV prevention programs for young, 
minority MSM.** The economic disparities described 
in this report are consistent with those reported 
among heterosexuals participating in NHBS.†† This 
reinforces the need for targeting prevention efforts to 
low-income populations, which might reduce HIV 
infection rates among MSM.
The findings in this report are subject to at least 
four limitations. First, because the survey was admin-
istered by an interviewer, positive HIV status might 
have been underreported during the interview, given 
the sensitive nature of the topic, thereby inflating esti-
mates of MSM unaware of their infections. Second, 
135 MSM who reported being HIV-positive but 
who had a negative or indeterminate HIV test result 
were excluded from analysis because of the possibil-
ity that they had false-negative NHBS test results; 
however, including these men as HIV-positive would 
have yielded a similar overall HIV prevalence (20% 
compared with 19%). Third, comparisons of the 
NHBS-MSM datasets collected during 2004–2005 
and 2008 should be made cautiously, because this 
analysis did not control for demographic differences 
in the samples, which might have influenced the 
percentages reported. Finally, these findings are lim-
ited to men who frequented MSM-identified venues 
(most of which were bars [45%] and dance clubs 
[22%]) during the survey period in 21 MSAs with 
high AIDS prevalence; the results are not representa-
tive of all MSM. A lower HIV prevalence (11.8%) 
has been reported among MSM in the general U.S. 
population (8).
The high proportion of MSM unaware of their 
HIV infection continues to be a serious public health 
concern, because these MSM account for the majority 
of estimated new HIV transmissions in the United 
States (9). Persons aware of their HIV infection often 
take substantial steps to reduce their risk behaviors, 
which could reduce HIV transmission (10). Whereas 
many MSM described in this report had not received 
an HIV test during the preceding 12 months, 45% of 
MSM who were unaware of their infection did report 
having an HIV test during the preceding 12 months, 
indicating they had acquired HIV recently or reported 
an incorrect HIV test result to the interviewer.
NHBS provides important information to guide 
and monitor HIV prevention efforts nationally and 
locally and will be critical for monitoring the impact 
of the National HIV/AIDS Strategy. The 2008 NHBS 
data show that MSM remain a key target of strate-
gies to reduce HIV incidence and decrease racial and 
socioeconomic disparities in the United States.
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Revision, with codes Q20.0–Q26.9 (excluding Q21.1, 
persistent foramen ovale§ and Q25.0, patent ductus 
arteriosus, because these are considered normal con-
ditions of prematurity). The analysis was restricted 
to infants of white and black mothers as reported on 
the birth certificate; those of Hispanic ethnicity and 
other racial/ethnic groups were excluded. Linked 
records with a missing gestational age (0.6% of the 
total), those with implausible gestational ages based 
on Alexander’s index of birth weight for gestational 
age norms (0.6%) (6), and those with gestational ages 
<20 weeks or >44 weeks (1.1%) were excluded.
Because not all infant death records could be 
linked to the corresponding birth certificate, esti-
mates of neonatal deaths were weighted according to 
the percentage of records linked by state and age at 
death. Poisson regression was used to calculate the rate 
ratio (RR) comparing neonatal mortality attributable 
to congenital heart defects among infants of black 
mothers with white mothers by gestational age group. 
Congenital heart defect neonatal mortality rates by 
weeks of gestational age also were estimated for infants 
of black mothers compared with white mothers. 
The analysis included 11,383,665 live births in the 
United States during 2003–2006. Overall, of 54,008 
neonatal deaths, 2,256 (4.2%) had a congenital heart 
defect noted as the underlying cause, including 1,777 
(5.4%) of 33,205 infants of white mothers and 479 
(2.3%) of 20,803 infants of black mothers. Deaths 
attributable to congenital heart defects were 24.5% 
of all neonatal deaths attributable to birth defects. 
The neonatal mortality rate attributable to congenital 
heart defects was 2.0 per 10,000 live births (Table 1). 
Hypoplastic left heart syndrome was the most com-
monly specified congenital heart defect–related 
underlying cause of neonatal death for infants of white 
(480 [27%]) and black (126 [26%]) mothers; 38% 
of the deaths were listed as “congenital malformation 
of heart, unspecified” (Table 2). A significantly lower 
proportion of neonatal deaths with transposition of 
the great arteries as the underlying cause occurred in 
infants of black mothers (2%) compared with white 
mothers (6%), but a significantly higher proportion of 
Congenital heart defects are diagnosed in approxi-
mately 1% of births in the United States (1) and 
account for the largest proportion of infant mor-
tality attributable to birth defects (2). Congenital 
heart defects are multifactorial in origin and have 
several recognized genetic causes (e.g., DiGeorge and 
Williams-Beuren syndromes) (3) and noninherited 
risk factors (e.g., maternal pregestational diabetes and 
rubella infection) (4). Approximately 70% of infant 
deaths attributable to congenital heart defects occur 
neonatally (age <28 days) (5). U.S. studies have shown 
that all-cause neonatal mortality rates are higher 
among term infants of black mothers compared with 
white mothers, but lower among preterm infants of 
black mothers compared with white mothers (6,7). 
To assess neonatal mortality attributable to congenital 
heart defects by maternal race and gestational age, 
CDC analyzed linked U.S. birth and infant death data 
for 2003–2006. This report summarizes the results of 
that analysis, which found that 4.2% of all neonatal 
deaths and 24.5% of neonatal deaths attributable to 
birth defects had a congenital heart defect noted as 
the underlying cause. Among preterm births (<37 
completed weeks’ gestation), neonatal mortality rates 
attributable to congenital heart defects were lower 
for blacks (4.5 per 10,000 live births) compared 
with whites (6.8). However, among term births (≥37 
completed weeks’ gestation), neonatal mortality rates 
attributable to congenital heart defects were higher 
for blacks (1.5 per 10,000 live births) than for whites 
(1.3). The reasons for these racial differences by gesta-
tional age are unclear and will require further exami-
nation, including assessment of differences in prenatal 
diagnosis and prevalence at birth of congenital heart 
defects, and reporting of causes of death.
This analysis used 2003–2006 linked* birth/
infant death data, the most recent available.† Included 
were records of all neonates (aged <28 days) whose 
underlying cause of death on the death certificate 
was classified as a congenital heart defect according 
to the International Classification of Diseases, 10th 
Racial Differences by Gestational Age in Neonatal Deaths Attributable 
to Congenital Heart Defects — United States, 2003–2006
§ Although Q21.1 includes atrial septal defects, most deaths coded to 
this category are persistent foramen ovale. For this reason, all Q21.1 
deaths were excluded from the analysis.
* Includes all infant deaths in a given year linked to their corresponding 
birth certificates, whether the birth occurred in that year or the 
previous year. Linkage completion by state ranged from 94% to 
100%; a mean of 27 states linked 100% of their records each year.
† Available at http://www.cdc.gov/nchs/data_access/vitalstatsonline.htm.
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neonatal deaths caused by pulmonary atresia occurred 
in infants of black mothers (3%) compared with white 
mothers (2%).
Preterm infants (born at <37 weeks’ gestation) 
accounted for 18% of the 2,312,080 births to black 
mothers and 11% of the 9,071,585 births to white 
mothers (Table 1). Neonatal mortality rates attributable 
to congenital heart defects varied by week of gestation 
and maternal race (Figure). Overall, neonatal mortal-
ity rates attributable to congenital heart defects were 
not significantly different when comparing infants 
of black mothers (2.1 per 10,000 live births) with 
infants of white mothers (2.0) (Rate ratio [RR] = 1.1; 
p = 0.28) (Table 1). However, the neonatal mortality 
rate attributable to congenital heart defects among 
preterm infants of black mothers (4.5 per 10,000) 
was significantly lower than that for preterm infants of 
white mothers (6.8) (RR = 0.7; p<0.001). In contrast, 
among infants delivered at 37–44 weeks, the neonatal 
mortality rate attributable to congenital heart defects 
among infants of black mothers (1.5 per 10,000) was 
higher than the neonatal mortality rate among infants 
of white mothers (1.3) (RR = 1.2; p = 0.03). 
Reported by
JR Petrini, PhD, Perinatal Data Center, March of Dimes 
National Office, Danbury Hospital, Danbury, Connecti-
cut. CS Broussard, PhD, SM Gilboa, PhD, KA Lee, MS, 
M Oster, MD, MA Honein, PhD, Div of Birth Defects 
and Developmental Disabilities, National Center on Birth 
Defects and Developmental Disabilities, CDC.
TABLE 1. Number and rate of neonatal deaths* attributable to congenital heart defects, by black or white maternal race and gestational age 




Total Black, non-Hispanic White, non-Hispanic
Rate 













20–36 885 1,442, 081 6.1 186  411,282 4.5 700 1,030,799 6.8 0.7  (0.6–0.8) <0.001
20–33 489 393,746 12.4 112 139,520 8.0 377 254,266 14.8 0.5  (0.4–0.7) <0.001
34–36 396 1,048,335 3.8 74 271,762 2.7 323 776,573 4.2 0.7 (0.5–0.8) 0.001
37–44 1,371 9,941,584 1.4 293 1,900,798 1.5 1,077 8,040,786 1.3 1.2 (1.0–1.3) 0.03
Total 2,256 11,383,665 2.0 479 2,312,080 2.1 1,777 9,071,585 2.0 1.1  (1.0–1.2) 0.28
* Deaths at age <28 days per 10,000 live births.
† Weighted to account for differences in the percentage of records linked by state and age at death.
§ Black non-Hispanic rate/white non-Hispanic rate.
¶ Confidence interval.
TABLE 2. Underlying causes of neonatal death* attributable to congenital heart defects listed on death certificates, by black or white maternal 
race — United States, 2003–2006
Underlying cause of death
Total Black, non-Hispanic White, non-Hispanic
Two-sample test 
of proportions 
p valueNo. (%) No. (%) No. (%)
Hypoplastic left heart syndrome 606 (27) 126 (26) 480 (27) 0.76
Transposition of the great arteries† 124 (6) 11 (2) 113 (6) 0.001
Coarctation of aorta 64 (3) 21 (4) 43 (2) 0.02
Ebstein’s anomaly 62 (3) 9 (2) 53 (3) 0.19
Congenital stenosis of aortic valve 57 (3) 7 (1) 50 (3) 0.09
Tetralogy of Fallot 52 (2) 8 (2) 44 (2) 0.30
Common arterial trunk 50 (2) 5 (1) 45 (3) 0.05
Atresia of pulmonary artery 47 (2) 16 (3) 31 (2) 0.03
Ventricular septal defect 37 (2) 9 (2) 28 (2) 0.64
Anomalous pulmonary venous connection, unspecified 22 (1) 7 (1) 15 (1) 0.22
Atrioventricular septal defect 20 (1) 4 (1) 16 (1) 0.89
Congenital tricuspid stenosis 19 (1) 5 (1) 14 (1) 0.59
Double inlet ventricle 16 (1) 6 (1) 10 (1) 0.11
Other specified congenital malformations of heart§ 83 (4) 22 (5) 61 (3) 0.23
Congenital malformation of heart, unspecified 848 (38) 197 (41) 651 (37) 0.07
Other causes§ 149 (7) 26 (5) 123 (7) 0.24
* Death at age <28 days.
† Category labeled “Discordant ventriculoarterial connection” in the International Classification of Diseases, 10th Revision (ICD-10).
§ In ICD-10, a single code exists for “Other specified congenital malformations of heart,” whereas the “Other causes” category includes multiple codes for less commonly 
specified causes.
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Editorial Note
The findings in this report indicate that although 
the overall neonatal mortality rate from congenital 
heart defects does not differ significantly between 
infants born to white and black mothers, differences 
can be observed by gestational age group. Among term 
infants, the rate for neonatal mortality attributable 
to congenital heart defects was 20% higher among 
infants of black mothers compared with white moth-
ers, but among preterm infants, the rate was 30% 
lower for infants of black mothers compared with 
white mothers. Similar patterns have been reported 
for all-cause neonatal mortality by gestational age 
group in the United States during 1989–2001 (7). 
Although reports of infant mortality attributable to 
any birth defect have indicated that infants born to 
black mothers had higher mortality rates than infants 
born to whites (2,5), these studies did not analyze the 
differences by gestational age.
The reason for the lower rate of all-cause neonatal 
mortality among preterm infants of black mothers 
compared with white mothers is unclear. One pos-
sibility is that live-born infants who die shortly after 
birth might be misclassified as fetal deaths, particu-
larly those born at early gestational ages (7). The fetal 
mortality rate in the United States is approximately 
twice as high among blacks as among whites (8), and 
differences by race in reporting fetal deaths versus 
early neonatal deaths might exist. Recent research has 
shown variation by state in classification of neonatal 
death at <24 hours versus fetal death for infants at 
the limits of viability (i.e., gestation of <24 weeks 
or birth weight <500 g) (9). Whether such variation 
might also occur by race is unknown. 
Also unclear is whether factors specific to congeni-
tal heart defects contribute to the differences in black 
and white neonatal mortality patterns by gestational 
age. Potentially, differences in prevalence of specific 
types of congenital heart defects might explain the 
differences in mortality patterns; however, previous 
studies examining congenital heart defect prevalence 
have not identified many racial differences in specific 
types of congenital heart defects or in congenital heart 
defects overall (1,10). Among studies that included 
birth defect prevalence among live births, stillbirths, 
and pregnancy terminations, no racial difference 
was observed for prevalence of hypoplastic left heart 
syndrome, the most common specific cause of death 
attributable to congenital heart defects (1,10). Some 
data have shown that infants of black mothers have a 
lower prevalence of transposition of the great arteries 
FIGURE. Rate of neonatal deaths* attributable to congenital heart defects, by gestational age and black or white 
maternal race — United States, 2003–2006 
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(1,10) and coartaction of the aorta (1), but a higher 
prevalence of tetralogy of Fallot (10) and pulmonary 
atresia/stenosis (1). 
The findings in this report are subject to at least 
three limitations. First, because of the large percentage 
of cases in which the underlying cause of death was 
unspecified, the results related to the distribution of 
specific causes should be interpreted with caution. 
Second, this analysis only included deaths with a 
congenital heart defect listed as the underlying cause; 
deaths were not included if congenital heart defects 
were instead classified as a contributing cause (e.g., 
Down syndrome as underlying with atrioventricular 
septal defect as contributing). However, such possible 
underestimation of deaths attributable to congenital 
heart defects would impact the analysis of racial dif-
ferences only if differential reporting of the underly-
ing cause of death occurred among racial groups. 
Finally, gestational age can be inaccurate on the birth 
certificate and might be less accurate among preterm 
births (6). Although cases with implausible gesta-
tional age/birth weight combinations were excluded, 
this analysis might have included some misclassified 
gestational ages.
Adjusting for gestational age or its correlates (such 
as birth weight), as has been done in some previous 
studies, obscures the differences in neonatal mortality 
rates by gestational age, and thus should be avoided. 
Efforts to reduce neonatal mortality rates attributable 
to congenital heart defects should include strategies 
to decrease mortality among infants with congenital 
heart defects through timely and appropriate medi-
cal and surgical treatment and to prevent the occur-
rence of congenital heart defects, where possible, by 
addressing modifiable potential risk factors such as 
pregestational diabetes, obesity, and maternal smok-
ing (4). The role of gestational age in differences 
in neonatal mortality among infants born to white 
and black mothers is unclear and requires further 
investigation, including assessment of differences in 
prenatal diagnosis, prevalence at birth of congenital 
heart defects, and reporting of causes of death.
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What is already known on this topic?
Congenital heart defects are associated with preterm 
delivery and are the largest contributor to neonatal 
mortality attributable to birth defects.
What is added by this report?
Neonatal mortality attributable to congenital heart 
defects was 30% lower among preterm infants born 
to black mothers compared with preterm infants 
born to white mothers in the United States during 
2003–2006; however, among term infants, those born 
to black mothers had 20% higher neonatal mortality 
attributable to congenital heart defects compared 
with those born to whites.
What are the implications for public health practice?
The reasons for racial differences by gestational age 
in neonatal mortality attributable to congenital heart 
defects are unclear and can only be understood 
through further examination, including assessment of 
differences in prenatal diagnosis, prevalence at birth 
of congenital heart defects, and reporting of causes 
of death.
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On September 21, this report was posted as an 
MMWR Early Release on the MMWR website (http://
www.cdc.gov/mmwr).
In July 2010, CDC was notified of a patient with a 
carbapenem-resistant Klebsiella pneumoniae strain that 
produced a Verona integron-encoded metallo-beta-
lactamase (VIM) carbapenemase (1) not reported pre-
viously among Enterobacteriaceae in the United States. 
The patient was a woman from the United States 
who became ill with diarrhea during a Mediterranean 
cruise and was hospitalized in Greece, where she 
received a diagnosis of sepsis and Clostridium difficile 
infection. After 12 days in two hospitals in Greece, 
she was transferred to a hospital in the United States 
for continued management of sepsis and acute renal 
failure. On admission, blood was drawn for culture 
through a central venous catheter that had been placed 
while the patient was hospitalized in Greece. The 
blood subsequently grew carbapenemase-producing 
Klebsiella pneumoniae exhibiting the VIM resistance 
mechanism, which has been described previously in 
Greece but not in the United States. Further testing 
showed the isolate to be nonsusceptible to all antimi-
crobials usually used to treat Klebsiella. Despite the 
resistance of the Klebsiella strain, the patient recovered 
sufficiently to be discharged after 26 days in the U.S. 
hospital. A search for other patients colonized with the 
same isolate was conducted by screening 22 patients 
whose U.S. hospital stays overlapped with this patient; 
no carbapenem-resistant Enterobacteriaceae (CRE) 
were detected.
This report of a VIM-producing CRE follows a June 
2010 report of three cases of New Delhi metallo-beta-
lactamase (NDM-1)–producing Enterobacteriaceae 
(2). However, the most common mechanism of car-
bapenem resistance among Enterobacteriaceae in the 
United States remains the production of the Klebsiella 
pneumoniae carbapenemase (KPC). KPC-producing 
Enterobacteriaceae are widespread in the United States 
and other countries (3). Cases of CRE are a signifi-
cant, emerging public health problem regardless of 
the mechanism of carbapenem resistance, and pro-
cedures to rapidly recognize and report CRE cases to 
infection prevention personnel should be in place in 
all acute and long-term–care facilities. Facilities that 
have not identified cases of CRE should undertake 
periodic laboratory reviews to identify cases. Patients 
with CRE should be managed using contact precau-
tions, and patients exposed to CRE patients (e.g., 
roommates) should be screened with surveillance 
cultures (3). State and local health departments should 
promote adoption of current prevention guidance 
and monitoring of the prevalence of these organisms 
in their jurisdictions (3). Public health officials and 
health-care facility staff can consult with the Division 
of Healthcare Quality Promotion at CDC on the best 
practices for identifying and preventing transmission 
of these organisms (e-mail: hip@cdc.gov).
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World Heart Day — September 26, 2010
Each year, approximately 17 million persons die 
from cardiovascular disease, mainly heart disease and 
stroke, making it the world’s leading cause of death 
(1). Controlling certain risk factors, such as high 
blood pressure, high cholesterol, diabetes, obesity, 
tobacco use, and physical inactivity, can help prevent 
heart disease and stroke.
This year marks the 10th anniversary of celebrat-
ing World Heart Day. In 2000, the World Heart 
Federation, a nongovernmental organization based 
in Geneva, Switzerland, created the annual World 
Heart Day campaign to increase public awareness of 
the threat of heart disease and stroke.
The theme of the 2010 World Heart Day is 
Workplace Wellness: Take Responsibility for Your 
Own Heart Health. Promoting physical activity and 
healthful eating and discouraging tobacco use around 
the workplace are simple ways to foster health in the 
workplace. Activities organized by members and 
partners of the World Heart Federation will include 
workplace campaigns, runs, public talks, concerts, 
and sporting events. The national member organiza-
tions in the United States are the American College of 
Cardiology and the American Heart Association.
CDC funds heart disease and stroke prevention 
programs in 41 states and the District of Columbia. 
Additional information about these programs is available 
at http://www.cdc.gov/dhdsp/state_program/index.htm. 
Information about World Heart Day and the World 
Heart Federation is available at http://www.world-heart-
federation.org/what-we-do/world-heart-day.
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Epi Info Training — December 2010
Emory University’s Rollins School of Public Health 
and CDC’s Office of Surveillance, Epidemiology, and 
Laboratory Services will cosponsor Epi Info basic 
level training December 6–8 and intermediate to 
advanced level training December 9–11, 2010, at 
Rollins School of Public Health in Atlanta, Georgia. 
Tuition will be charged.
The Epi Info courses are designed for practitioners 
of epidemiology and computing who wish to develop 
software applications using Epi Info for Windows. 
The basic level course covers  MakeView, Analysis, 
Enter, Epi Map, and Epi Report. The intermediate 
to advanced level covers importing and converting 
other data formats; creating relational databases; 
advanced checkcoding and using Epi Info functions; 
advanced analysis, including linear regression, logistic 
regression, Kaplan Meier, Cox Proportional Hazards, 
complex sample frequencies, tables, and means; spe-
cial topics on Epi Map and Epi Report; and issues 
related to participants’ own projects.
Additional information and applications are avail-
able by mail (Emory University, Hubert Department 
of Global Health [Attn: Pia], 1518 Clifton Rd. NE, 
CNR Bldg., Rm. 7038, Atlanta, GA 30322); tele-
phone (404-727-3485); fax (404-727-4590); Internet 
(http://www.sph.emory.edu/epicourses), or e-mail 
(pvaleri@emory.edu).
Epidemiology in Action: Intermediate 
Analytic Methods Course
Emory University’s Rollins School of Public Health 
and CDC will cosponsor the course Epidemiology in 
Action: Intermediate Analytic Methods, January 
11–14, 2011, at Rollins School of Public Health in 
Atlanta, Georgia. The course is designed for practicing 
public health professionals who have had training and 
experience in basic applied epidemiology and would 
like training in additional quantitative skills related to 
analysis and interpretation of epidemiologic data.
The course includes a review of the fundamentals 
of descriptive epidemiology and biostatistics, measures 
of association, normal and binomial distributions, 
confounding, statistical tests, stratification, logistic 
regression models, and computer programs as used 
in epidemiology.
The prerequisite is an introductory course in 
epidemiology, such as Epidemiology in Action or 
the International Course in Applied Epidemiology. 
Tuition will be charged. The application deadline is 
December 13, 2010, or until all slots are filled.
Additional information and applications are avail-
able by mail (Emory University, Hubert Department 
of Global Health [Attn: Pia], 1518 Clifton Rd. NE, 
CNR Bldg., Rm. 7038, Atlanta, GA 30322); tele-
phone (404-727-3485); fax (404-727-4590); Internet 
(http://www.sph.emory.edu/epicourses), or e-mail 
(pvaleri@emory.edu).
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TABLE I. Provisional cases of infrequently reported notifiable diseases (<1,000 cases reported during the preceding year) — United States, week ending 









Total cases reported 
for previous years States reporting cases 
during current week (No.)2009 2008 2007 2006 2005
Anthrax — — 0 1 — 1 1 —
Botulism, total 2 65 2 118 145 144 165 135
 foodborne — 6 0 10 17 32 20 19
 infant 1 46 2 83 109 85 97 85 OH (1)
 other (wound and unspecified) 1 13 0 25 19 27 48 31 WA (1)
Brucellosis 2 88 2 115 80 131 121 120 FL (2)
Chancroid — 31 0 28 25 23 33 17
Cholera — 5 0 10 5 7 9 8)
Cyclosporiasis§ 2 134 2 141 139 93 137 543 NY (2)
Diphtheria — — — — — — — —
Domestic arboviral diseases § ,¶:
 California serogroup virus disease — 30 3 55 62 55 67 80
 Eastern equine encephalitis virus disease — 10 0 4 4 4 8 21
 Powassan virus disease — 4 0 6 2 7 1 1
 St. Louis encephalitis virus disease — 4 1 12 13 9 10 13
 Western equine encephalitis virus disease — — — — — — — —
Haemophilus influenzae,** invasive disease (age <5 yrs):
 serotype b — 10 0 35 30 22 29 9
 nonserotype b 1 130 3 236 244 199 175 135 TN (1)
 unknown serotype 2 160 2 178 163 180 179 217 MO (2)
Hansen disease§ 2 31 2 103 80 101 66 87 FL (1), CA (1)
Hantavirus pulmonary syndrome§ — 15 1 20 18 32 40 26
Hemolytic uremic syndrome, postdiarrheal§ 7 139 8 242 330 292 288 221 CT (1), FL (1), TN (1), CA (4)
HIV infection, pediatric (age <13 yrs)†† — — 1 — — — — 380
Influenza-associated pediatric mortality§,§§ — 56 2 358 90 77 43 45
Listeriosis 6 550 23 851 759 808 884 896 NY (1), PA (1), OH (1), GA (1), WA (1), CA (1)
Measles¶¶ — 48 1 71 140 43 55 66
Meningococcal disease, invasive***:
 A, C, Y, and W-135 1 178 4 301 330 325 318 297 ND (1)
 serogroup B 1 83 2 174 188 167 193 156 TX (1)
 other serogroup — 7 0 23 38 35 32 27
 unknown serogroup 3 269 8 482 616 550 651 765 FL (1), TX (2)
Mumps 8 2,350 17 1,991 454 800 6,584 314 NY (3), NYC (3), CA (2)
Novel influenza A virus infections††† — 1 0 43,774 2 4 NN NN
Plague — 1 0 8 3 7 17 8
Poliomyelitis, paralytic — — 0 1 — — — 1
Polio virus Infection, nonparalytic§ — — — — — — NN NN
Psittacosis§ — 4 0 9 8 12 21 16
Q fever, total§,§§§ 1 80 3 114 120 171 169 136
 acute 1 62 1 94 106 — — — MO (1)
 chronic — 18 0 20 14 — — —
Rabies, human — 1 0 4 2 1 3 2
Rubella¶¶¶ — 6 0 3 16 12 11 11
Rubella, congenital syndrome — — — 2 — — 1 1
SARS-CoV§,**** — — — — — — — —
Smallpox§ — — — — — — — —
Streptococcal toxic-shock syndrome§ — 124 1 161 157 132 125 129
Syphilis, congenital (age <1 yr)†††† — 139 8 423 431 430 349 329
Tetanus — 4 1 18 19 28 41 27
Toxic-shock syndrome (staphylococcal)§ — 56 2 74 71 92 101 90
Trichinellosis — 2 0 13 39 5 15 16
Tularemia 2 72 3 93 123 137 95 154 AR (2)
Typhoid fever 4 262 13 397 449 434 353 324 NY (1), MD (1), CA (2)
Vancomycin-intermediate Staphylococcus aureus§ — 64 1 78 63 37 6 2
Vancomycin-resistant Staphylococcus aureus§ — 1 — 1 — 2 1 3
Vibriosis (noncholera Vibrio species infections)§ 15 524 14 789 588 549 NN NN MD (1), FL (1), TX (1), AZ (1), WA (5), CA (6)
Viral hemorrhagic fever§§§§ — 1 — NN NN NN NN NN
Yellow fever — — — — — — — —
See Table I footnotes on next page.
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Notifiable Disease Data Team and 122 Cities Mortality Data Team
 Patsy A. Hall-Baker
Deborah A. Adams  Rosaline Dhara
Willie J. Anderson  Pearl C. Sharp
Michael S. Wodajo  Lenee Blanton
* Ratio of current 4-week total to mean of 15 4-week totals (from previous, comparable, and subsequent 4-week periods for the 
past 5 years). The point where the hatched area begins is based on the mean and two standard deviations of these 4-week 
totals.
FIGURE I. Selected notifiable disease reports, United States, comparison of provisional 4-week 


























TABLE I. (Continued) Provisional cases of infrequently reported notifiable diseases (<1,000 cases reported during the preceding year) — United States, week 
ending September 18, 2010 (37th week)*
—: No reported cases. N: Not reportable. NN: Not Nationally Notifiable Cum: Cumulative year-to-date counts.
 * Incidence data for reporting years 2009 and 2010 are provisional, whereas data for 2005 through 2008 are finalized.
 † Calculated by summing the incidence counts for the current week, the 2 weeks preceding the current week, and the 2 weeks following the current week, for a total of 5 preceding years. 
Additional information is available at http://www.cdc.gov/ncphi/disss/nndss/phs/files/5yearweeklyaverage.pdf.
 § Not reportable in all states. Data from states where the condition is not reportable are excluded from this table except starting in 2007 for the domestic arboviral diseases, STD data, TB 
data, and influenza-associated pediatric mortality, and in 2003 for SARS-CoV.  Reporting exceptions are available at http://www.cdc.gov/ncphi/disss/nndss/phs/infdis.htm.
 ¶ Includes both neuroinvasive and nonneuroinvasive. Updated weekly from reports to the Division of Vector-Borne Infectious Diseases, National Center for Zoonotic, Vector-Borne, and 
Enteric Diseases (ArboNET Surveillance). Data for West Nile virus are available in Table II.
 ** Data for H. influenzae (all ages, all serotypes) are available in Table II.
 †† Updated monthly from reports to the Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Implementation of HIV reporting influences 
the number of cases reported. Updates of pediatric HIV data have been temporarily suspended until upgrading of the national HIV/AIDS surveillance data management system is 
completed. Data for HIV/AIDS, when available, are displayed in Table IV, which appears quarterly.
 §§ Updated weekly from reports to the Influenza Division, National Center for Immunization and Respiratory Diseases. Since April 26, 2009, a total of 286 influenza-associated pediatric 
deaths associated with 2009 influenza A (H1N1) virus infection have been reported. Since August 30, 2009, a total of 281 influenza-associated pediatric deaths occurring during the 
2009–10 influenza season have been reported. A total of 133 influenza-associated pediatric deaths occurring during the 2008-09 influenza season have been reported.
 ¶¶ No measles cases were reported for the current week.
 *** Data for meningococcal disease (all serogroups) are available in Table II.
 ††† CDC discontinued reporting of individual confirmed and probable cases of 2009 pandemic influenza A (H1N1) virus infections on July 24, 2009. During 2009, three cases of novel 
influenza A virus infections, unrelated to the 2009 pandemic influenza A (H1N1) virus, were reported to CDC. The one case of novel influenza A virus infection reported to CDC during 
2010 was identified as swine influenza A (H3N2) virus and is unrelated to pandemic influenza A (H1N1) virus.  Total case count for 2009 was provided by the Influenza Division,  National 
Center for Immunization and Respiratory Diseases (NCIRD).
 §§§ In 2009, Q fever acute and chronic reporting categories were recognized as a result of revisions to the Q fever case definition. Prior to that time, case counts were not differentiated with 
respect to acute and chronic Q fever cases.
 ¶¶¶ No rubella cases were reported for the current week.
 **** Updated weekly from reports to the Division of Viral and Rickettsial Diseases, National Center for Zoonotic, Vector-Borne, and Enteric Diseases.
 †††† Updated weekly from reports to the Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
 §§§§ There was one case of viral hemorrhagic fever reported during week 12. The one case report was confirmed as lassa fever. See Table II for dengue hemorrhagic fever.
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TABLE II. Provisional cases of selected notifiable diseases, United States, weeks ending September 18, 2010, and September 19, 2009 (37th week)*
Reporting area
Chlamydia trachomatis infection Cryptosporidiosis
Current  
week






Previous 52 weeks Cum  
2010
Cum  
2009Med Max Med Max
United States 11,327 22,858 26,113 814,298 894,810 132 122 290 5,345 5,254
New England 520 742 1,396 27,594 28,699 3 8 68 350 340
Connecticut — 221 736 6,788 8,201 — 0 62 62 38
Maine† 43 50 75 1,807 1,718 1 1 7 63 39
Massachusetts 416 396 638 14,091 13,751 2 3 8 120 140
New Hampshire 25 40 116 1,663 1,527 — 1 5 44 64
Rhode Island† — 65 120 2,377 2,671 — 0 8 9 8
Vermont† 36 23 63 868 831 — 1 9 52 51
Mid. Atlantic 2,847 3,252 4,619 120,409 111,906 11 15 37 584 594
New Jersey 452 489 698 18,711 17,458 — 0 3 — 41
New York (Upstate) 707 674 2,530 24,139 21,753 8 3 16 157 154
New York City 1,265 1,194 2,143 44,547 41,622 — 1 5 55 67
Pennsylvania 423 890 1,091 33,012 31,073 3 9 26 372 332
E.N. Central 757 3,526 4,413 121,407 144,793 19 30 102 1,389 1,281
Illinois 10 828 1,322 24,936 44,217 — 3 15 140 119
Indiana — 349 786 13,221 16,882 — 4 10 133 215
Michigan 464 897 1,420 34,127 33,481 2 5 17 241 207
Ohio 153 964 1,078 34,304 35,070 12 7 24 338 291
Wisconsin 130 413 500 14,819 15,143 5 10 48 537 449
W.N. Central 371 1,333 1,592 47,499 51,049 45 24 72 975 770
Iowa 7 186 293 6,965 6,989 — 4 20 227 161
Kansas 10 187 235 6,675 7,816 1 2 9 106 77
Minnesota — 273 337 9,649 10,373 — 2 30 98 196
Missouri 187 491 606 17,220 18,670 18 4 26 278 145
Nebraska† 93 94 237 3,481 3,881 26 2 17 180 82
North Dakota 61 35 93 1,375 1,196 — 0 18 16 7
South Dakota 13 60 82 2,134 2,124 — 2 7 70 102
S. Atlantic 3,023 4,504 5,681 161,307 181,993 9 19 51 734 798
Delaware 220 84 156 3,126 3,371 — 0 2 5 8
District of Columbia — 96 177 3,386 5,038 — 0 1 2 6
Florida 683 1,403 1,669 52,891 53,267 4 8 24 274 293
Georgia — 383 1,323 12,198 29,314 2 5 31 221 269
Maryland† — 454 1,031 15,735 16,150 — 1 3 29 34
North Carolina 718 797 1,562 29,781 30,130 — 1 12 55 82
South Carolina† 732 520 692 19,428 19,742 — 1 8 62 44
Virginia† 594 596 902 22,126 22,357 — 2 8 71 51
West Virginia 76 70 137 2,636 2,624 3 0 2 15 11
E.S. Central 1,144 1,696 2,416 62,434 67,611 3 4 17 195 158
Alabama† 627 482 665 18,302 19,417 — 1 10 83 48
Kentucky 262 290 642 11,065 9,218 — 1 6 57 43
Mississippi — 389 780 13,074 17,308 — 0 3 10 15
Tennessee† 255 581 732 19,993 21,668 3 1 5 45 52
W.S. Central 458 2,857 4,578 103,648 117,676 20 8 39 285 391
Arkansas† 365 244 402 7,940 10,419 — 1 4 25 40
Louisiana — 0 1,055 2,922 20,948 1 1 5 40 37
Oklahoma 93 261 1,375 11,138 10,588 4 1 9 65 85
Texas† — 2,220 3,201 81,648 75,721 15 4 30 155 229
Mountain 393 1,432 2,081 48,132 56,009 8 10 27 397 419
Arizona 181 444 713 13,551 18,606 — 0 3 25 26
Colorado — 380 709 12,365 13,075 — 2 8 98 112
Idaho† — 63 191 2,184 2,563 2 2 6 68 68
Montana† 39 58 76 2,138 2,166 — 1 4 37 45
Nevada† 149 175 337 6,862 7,394 6 0 4 28 16
New Mexico† — 172 453 5,465 6,382 — 2 8 78 106
Utah — 117 175 4,146 4,441 — 1 4 50 31
Wyoming† 24 38 79 1,421 1,382 — 0 2 13 15
Pacific 1,814 3,449 5,350 121,868 135,074 14 12 28 436 503
Alaska — 108 148 4,155 3,817 — 0 1 2 6
California 1,814 2,735 4,406 98,994 103,476 7 8 19 248 293
Hawaii — 112 158 3,875 4,376 — 0 0 — 1
Oregon — 0 468 1,367 7,808 5 2 11 124 148
Washington — 393 497 13,477 15,597 2 2 8 62 55
Territories
American Samoa — 0 0 — — N 0 0 N N
C.N.M.I. — — — — — — — — — —
Guam — 4 31 187 272 — 0 0 — —
Puerto Rico 90 95 265 3,738 5,415 N 0 0 N N
U.S. Virgin Islands — 10 29 323 375 — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional. Data for HIV/AIDS, AIDS, and TB, when available, are displayed in Table IV, which appears quarterly.
† Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending September 18, 2010, and September 19, 2009 (37th week)*
Dengue Virus Infection
Reporting area
Dengue Fever† Dengue Hemorrhagic Fever§
Current  
week






Previous 52 weeks Cum  
2010
Cum  
2009Med Max Med Max
United States — 4 25 286 NN — 0 1 2 NN
New England — 0 2 4 NN — 0 0 — NN
Connecticut — 0 0 — NN — 0 0 — NN
Maine¶ — 0 2 3 NN — 0 0 — NN
Massachusetts — 0 0 — NN — 0 0 — NN
New Hampshire — 0 0 — NN — 0 0 — NN
Rhode Island¶ — 0 0 — NN — 0 0 — NN
Vermont¶ — 0 1 1 NN — 0 0 — NN
Mid. Atlantic — 0 9 74 NN — 0 0 — NN
New Jersey — 0 0 — NN — 0 0 — NN
New York (Upstate) — 0 0 — NN — 0 0 — NN
New York City — 0 7 62 NN — 0 0 — NN
Pennsylvania — 0 2 12 NN — 0 0 — NN
E.N. Central — 0 2 24 NN — 0 0 — NN
Illinois — 0 0 — NN — 0 0 — NN
Indiana — 0 2 8 NN — 0 0 — NN
Michigan — 0 1 4 NN — 0 0 — NN
Ohio — 0 2 9 NN — 0 0 — NN
Wisconsin — 0 1 3 NN — 0 0 — NN
W.N. Central — 0 3 15 NN — 0 0 — NN
Iowa — 0 1 1 NN — 0 0 — NN
Kansas — 0 0 — NN — 0 0 — NN
Minnesota — 0 2 10 NN — 0 0 — NN
Missouri — 0 1 3 NN — 0 0 — NN
Nebraska¶ — 0 0 — NN — 0 0 — NN
North Dakota — 0 1 1 NN — 0 0 — NN
South Dakota — 0 0 — NN — 0 0 — NN
S. Atlantic — 1 15 147 NN — 0 1 1 NN
Delaware — 0 0 — NN — 0 0 — NN
District of Columbia — 0 0 — NN — 0 0 — NN
Florida — 1 14 129 NN — 0 1 1 NN
Georgia — 0 2 7 NN — 0 0 — NN
Maryland¶ — 0 0 — NN — 0 0 — NN
North Carolina — 0 1 1 NN — 0 0 — NN
South Carolina¶ — 0 3 8 NN — 0 0 — NN
Virginia¶ — 0 0 — NN — 0 0 — NN
West Virginia — 0 1 2 NN — 0 0 — NN
E.S. Central — 0 1 2 NN — 0 0 — NN
Alabama¶ — 0 1 1 NN — 0 0 — NN
Kentucky — 0 0 — NN — 0 0 — NN
Mississippi — 0 0 — NN — 0 0 — NN
Tennessee¶ — 0 1 1 NN — 0 0 — NN
W.S. Central — 0 1 1 NN — 0 1 1 NN
Arkansas¶ — 0 0 — NN — 0 1 1 NN
Louisiana — 0 0 — NN — 0 0 — NN
Oklahoma — 0 1 1 NN — 0 0 — NN
Texas¶ — 0 0 — NN — 0 0 — NN
Mountain — 0 1 9 NN — 0 0 — NN
Arizona — 0 1 2 NN — 0 0 — NN
Colorado — 0 0 — NN — 0 0 — NN
Idaho¶ — 0 0 — NN — 0 0 — NN
Montana¶ — 0 1 2 NN — 0 0 — NN
Nevada¶ — 0 1 4 NN — 0 0 — NN
New Mexico¶ — 0 1 1 NN — 0 0 — NN
Utah — 0 0 — NN — 0 0 — NN
Wyoming¶ — 0 0 — NN — 0 0 — NN
Pacific — 0 2 10 NN — 0 0 — NN
Alaska — 0 0 — NN — 0 0 — NN
California — 0 1 4 NN — 0 0 — NN
Hawaii — 0 0 — NN — 0 0 — NN
Oregon — 0 0 — NN — 0 0 — NN
Washington — 0 2 6 NN — 0 0 — NN
Territories
American Samoa — 0 0 — NN — 0 0 — NN
C.N.M.I. — — — — NN — — — — NN
Guam — 0 0 — NN — 0 0 — NN
Puerto Rico — 85 515 6,517 NN — 0 3 28 NN
U.S. Virgin Islands — 0 0 — NN — 0 0 — NN
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Dengue Fever includes cases that meet criteria for Dengue Fever with hemorrhage, other clinical, and unknown case classifications.
§ DHF includes cases that meet criteria for dengue shock syndrome (DSS), a more severe form of DHF.
¶ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending September 18, 2010, and September 19, 2009 (37th week)*
Ehrlichiosis/Anaplasmosis†
Reporting area
Ehrlichia chaffeensis Anaplasma phagocytophilum Undetermined
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 4 11 181 463 738 12 13 309 468 695 2 2 35 76 146
New England — 0 3 3 39 — 1 17 52 207 — 0 2 7 2
Connecticut — 0 0 — — — 0 13 18 3 — 0 2 5 —
Maine§ — 0 1 2 3 — 0 2 13 12 — 0 0 — —
Massachusetts — 0 0 — 9 — 0 4 — 83 — 0 0 — —
New Hampshire — 0 1 1 3 — 0 3 9 15 — 0 1 2 1
Rhode Island§ — 0 2 — 23 — 0 7 12 94 — 0 0 — 1
Vermont§ — 0 0 — 1 — 0 0 — — — 0 0 — —
Mid. Atlantic — 1 15 37 136 10 3 17 153 219 — 0 2 4 41
New Jersey — 0 6 — 79 — 0 2 1 61 — 0 0 — —
New York (Upstate) — 1 15 22 36 10 3 17 149 152 — 0 1 4 5
New York City — 0 3 14 8 — 0 1 3 5 — 0 0 — 1
Pennsylvania — 0 5 1 13 — 0 1 — 1 — 0 1 — 35
E.N. Central — 0 4 24 75 1 2 27 190 242 1 1 4 43 63
Illinois — 0 2 10 32 — 0 1 1 6 — 0 2 3 3
Indiana — 0 0 — — — 0 0 — — 1 0 3 24 34
Michigan — 0 1 2 4 — 0 0 — — — 0 1 3 —
Ohio — 0 3 6 11 — 0 1 1 1 — 0 0 — 2
Wisconsin — 0 3 6 28 1 2 27 188 235 — 0 3 13 24
W.N. Central — 2 13 109 137 — 0 261 8 7 1 0 30 12 16
Iowa — 0 0 — — — 0 0 — — — 0 0 — —
Kansas — 0 1 6 6 — 0 0 — 1 — 0 0 — —
Minnesota — 0 6 — 1 — 0 261 — 3 — 0 30 — 3
Missouri — 1 13 102 128 — 0 3 8 2 1 0 3 12 13
Nebraska§ — 0 1 1 2 — 0 0 — 1 — 0 0 — —
North Dakota — 0 0 — — — 0 0 — — — 0 0 — —
South Dakota — 0 0 — — — 0 0 — — — 0 0 — —
S. Atlantic — 4 19 196 209 1 0 7 47 14 — 0 1 3 2
Delaware — 0 3 16 16 — 0 1 4 2 — 0 0 — —
District of Columbia — 0 0 — — — 0 0 — — — 0 0 — —
Florida — 0 2 8 9 — 0 1 3 3 — 0 0 — —
Georgia — 0 4 16 17 — 0 1 1 1 — 0 1 1 —
Maryland§ — 0 3 19 34 — 0 2 11 3 — 0 1 2 —
North Carolina — 1 13 75 54 — 0 4 17 3 — 0 0 — —
South Carolina§ — 0 2 3 8 — 0 0 — — — 0 0 — —
Virginia§ — 1 13 59 70 1 0 2 11 2 — 0 0 — 2
West Virginia — 0 0 — 1 — 0 0 — — — 0 1 — —
E.S. Central 1 1 10 73 109 — 0 2 16 3 — 0 2 6 22
Alabama§ — 0 3 10 6 — 0 2 7 1 — 0 0 — —
Kentucky — 0 2 11 9 — 0 0 — — — 0 0 — —
Mississippi — 0 1 3 6 — 0 1 1 — — 0 0 — —
Tennessee§ 1 1 10 49 88 — 0 2 8 2 — 0 2 6 22
W.S. Central 3 0 141 20 30 — 0 23 2 1 — 0 1 1 —
Arkansas§ — 0 34 2 4 — 0 6 — — — 0 0 — —
Louisiana — 0 1 1 — — 0 0 — — — 0 0 — —
Oklahoma 3 0 105 14 24 — 0 16 2 1 — 0 0 — —
Texas§ — 0 2 3 2 — 0 1 — — — 0 1 1 —
Mountain — 0 0 — — — 0 0 — — — 0 1 — —
Arizona — 0 0 — — — 0 0 — — — 0 1 — —
Colorado — 0 0 — — — 0 0 — — — 0 0 — —
Idaho§ — 0 0 — — — 0 0 — — — 0 0 — —
Montana§ — 0 0 — — — 0 0 — — — 0 0 — —
Nevada§ — 0 0 — — — 0 0 — — — 0 0 — —
New Mexico§ — 0 0 — — — 0 0 — — — 0 0 — —
Utah — 0 0 — — — 0 0 — — — 0 0 — —
Wyoming§ — 0 0 — — — 0 0 — — — 0 0 — —
Pacific — 0 1 1 3 — 0 0 — 2 — 0 1 — —
Alaska — 0 0 — — — 0 0 — — — 0 0 — —
California — 0 1 1 3 — 0 0 — 2 — 0 1 — —
Hawaii — 0 0 — — — 0 0 — — — 0 0 — —
Oregon — 0 0 — — — 0 0 — — — 0 0 — —
Washington — 0 0 — — — 0 0 — — — 0 0 — —
Territories
American Samoa — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 0 — — — 0 0 — — — 0 0 — —
Puerto Rico — 0 0 — — — 0 0 — — — 0 0 — —
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Cumulative total E. ewingii cases reported for year 2010 = 10.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
MMWR  Morbidity and Mortality Weekly Report
 MMWR  /  September 24, 2010  /  Vol. 59  /  No. 37 1219 
TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending September 18, 2010, and September 19, 2009 (37th week)*
Reporting area
Giardiasis Gonorrhea
Haemophilus influenzae, invasive†  
All ages, all serotypes
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 274 344 666 12,302 13,122 2,872 5,405 6,656 190,159 217,726 20 59 171 2,082 2,142
New England 17 31 65 1,078 1,215 90 103 196 3,711 3,459 — 3 21 121 145
Connecticut — 5 15 187 218 — 45 169 1,619 1,605 — 0 15 25 42
Maine§ 6 4 12 151 162 1 3 11 125 100 — 0 2 10 16
Massachusetts 6 13 33 463 522 84 43 72 1,625 1,396 — 2 8 65 68
New Hampshire — 3 9 106 149 4 2 7 109 79 — 0 2 8 8
Rhode Island§ — 1 7 35 41 — 5 13 187 248 — 0 1 7 7
Vermont§ 5 4 14 136 123 1 0 17 46 31 — 0 1 6 4
Mid. Atlantic 41 60 112 2,102 2,395 657 674 941 24,924 22,313 3 11 34 412 424
New Jersey — 6 15 192 320 94 103 164 3,961 3,386 — 2 7 66 98
New York (Upstate) 28 22 84 792 888 149 104 422 3,941 4,030 2 3 20 108 104
New York City 6 16 31 604 599 281 227 394 8,648 7,826 — 2 6 82 52
Pennsylvania 7 14 37 514 588 133 217 295 8,374 7,071 1 4 9 156 170
E.N. Central 23 52 92 1,903 2,074 221 959 1,536 33,065 46,139 2 9 20 349 332
Illinois — 11 20 375 453 2 187 441 5,697 14,773 — 2 9 98 127
Indiana — 6 14 191 203 — 91 217 3,708 5,490 — 1 6 66 58
Michigan 5 13 25 468 468 144 249 502 9,548 10,688 — 0 4 26 17
Ohio 16 16 28 592 581 41 316 372 10,888 11,422 2 2 6 87 76
Wisconsin 2 8 22 277 369 34 92 155 3,224 3,766 — 2 5 72 54
W.N. Central 33 25 165 1,041 1,175 82 274 367 9,591 10,760 4 3 24 123 123
Iowa 2 5 11 208 227 2 32 53 1,182 1,210 — 0 1 1 —
Kansas 4 4 10 164 114 1 39 83 1,368 1,842 — 0 2 12 13
Minnesota — 0 135 136 250 1 40 64 1,342 1,686 — 0 17 25 43
Missouri 23 8 15 294 378 54 123 172 4,537 4,714 4 1 6 61 43
Nebraska§ 2 4 9 161 126 22 22 50 814 974 — 0 2 15 19
North Dakota 2 0 8 18 8 1 2 11 94 88 — 0 4 9 5
South Dakota — 2 10 60 72 1 6 16 254 246 — 0 0 — —
S. Atlantic 82 75 143 2,690 2,558 969 1,297 1,651 46,823 54,311 6 14 27 556 589
Delaware — 0 5 24 18 48 18 34 713 676 — 0 1 5 3
District of Columbia — 1 4 23 49 — 38 65 1,304 1,973 — 0 1 2 2
Florida 75 39 87 1,510 1,356 226 381 468 14,256 15,480 — 3 9 130 180
Georgia — 13 51 485 526 — 141 494 4,263 9,892 1 3 9 135 114
Maryland§ 3 6 12 194 200 — 132 237 4,540 4,371 1 1 6 45 71
North Carolina N 0 0 N N 266 259 596 9,988 10,345 4 2 9 97 70
South Carolina§ 1 2 9 105 74 239 153 230 5,866 6,135 — 2 7 65 57
Virginia§ 1 9 36 322 301 175 163 271 5,530 5,064 — 2 4 61 68
West Virginia 2 1 5 27 34 15 8 20 363 375 — 0 5 16 24
E.S. Central 1 5 22 176 289 296 472 700 16,970 19,539 1 3 12 125 136
Alabama§ — 4 8 123 146 180 140 217 5,338 5,544 — 0 3 20 34
Kentucky N 0 0 N N 54 76 156 2,877 2,689 — 0 2 24 19
Mississippi N 0 0 N N — 111 216 3,663 5,405 — 0 2 10 7
Tennessee§ 1 2 18 53 143 62 146 197 5,092 5,901 1 2 10 71 76
W.S. Central 4 8 18 256 359 159 771 1,227 27,660 34,343 4 2 20 96 91
Arkansas§ 2 2 9 83 98 117 73 139 2,425 3,201 1 0 3 13 15
Louisiana 2 3 9 110 144 — 0 343 910 6,817 — 0 3 17 16
Oklahoma — 2 7 63 117 42 80 359 3,241 3,349 3 1 15 59 57
Texas§ N 0 0 N N — 573 962 21,084 20,976 — 0 2 7 3
Mountain 8 30 45 1,130 1,191 56 168 266 5,680 6,647 — 5 15 219 188
Arizona 2 3 7 108 149 30 56 109 1,592 2,201 — 2 10 83 61
Colorado — 13 27 489 351 — 52 127 1,761 1,997 — 1 5 65 53
Idaho§ 4 4 9 144 139 — 2 6 61 76 — 0 2 12 3
Montana§ 1 2 11 76 92 1 2 6 80 54 — 0 1 2 1
Nevada§ 1 1 11 73 85 25 29 94 1,223 1,288 — 0 2 6 14
New Mexico§ — 2 5 62 97 — 20 41 716 765 — 1 5 30 26
Utah — 4 11 154 230 — 6 15 222 214 — 0 4 16 27
Wyoming§ — 1 5 24 48 — 1 4 25 52 — 0 2 5 3
Pacific 65 54 133 1,926 1,866 342 578 788 21,735 20,215 — 2 9 81 114
Alaska — 2 7 68 80 — 23 37 897 684 — 0 2 16 13
California 49 33 61 1,220 1,221 342 483 692 18,508 16,642 — 0 4 12 39
Hawaii — 0 4 21 16 — 13 24 481 444 — 0 2 5 26
Oregon 8 9 15 330 286 — 0 43 106 790 — 1 5 44 33
Washington 8 8 75 287 263 — 48 66 1,743 1,655 — 0 4 4 3
Territories
American Samoa — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 1 2 3 — 0 4 20 16 — 0 0 — —
Puerto Rico — 1 8 27 126 11 5 14 194 177 — 0 1 1 4
U.S. Virgin Islands — 0 0 — — — 2 7 78 95 — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Data for H. influenzae (age <5 yrs for serotype b, nonserotype b, and unknown serotype) are available in Table I.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending September 18, 2010, and September 19, 2009 (37th week)*

















Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 22 30 69 1,061 1,442 41 59 204 2,126 2,374 15 15 44 590 530
New England 1 2 5 73 83 — 1 5 39 43 — 1 4 26 48
Connecticut 1 0 3 23 17 — 0 2 13 13 — 0 3 17 37
Maine† — 0 1 7 1 — 0 2 11 9 — 0 1 — 1
Massachusetts — 1 4 36 51 — 0 2 8 17 — 0 1 9 9
New Hampshire — 0 1 1 7 — 0 2 5 4 N 0 0 N N
Rhode Island† — 0 4 6 5 U 0 0 U U U 0 0 U U
Vermont† — 0 0 — 2 — 0 1 2 — — 0 0 — 1
Mid. Atlantic 4 4 10 138 205 — 5 10 209 254 1 2 6 77 73
New Jersey — 0 3 11 57 — 1 5 51 78 — 0 2 7 5
New York (Upstate) 4 1 3 43 35 — 1 6 38 41 1 1 4 47 34
New York City — 1 4 48 62 — 2 4 62 49 — 0 1 — 4
Pennsylvania — 1 6 36 51 — 1 5 58 86 — 0 3 23 30
E.N. Central 3 4 8 138 224 — 8 14 306 329 — 2 8 99 68
Illinois — 1 3 28 103 — 2 6 61 86 — 0 1 1 4
Indiana — 0 2 15 15 — 1 5 41 53 — 0 2 21 14
Michigan — 1 4 41 53 — 2 6 89 100 — 1 6 63 24
Ohio 3 0 5 31 31 — 2 6 79 72 — 0 1 8 23
Wisconsin — 0 3 23 22 — 1 3 36 18 — 0 1 6 3
W.N. Central — 1 13 53 87 — 2 15 79 101 — 0 11 17 10
Iowa — 0 3 5 29 — 0 2 11 27 — 0 4 1 4
Kansas — 0 2 10 7 — 0 2 5 5 — 0 0 — 1
Minnesota — 0 12 13 14 — 0 13 6 17 — 0 9 9 2
Missouri — 0 2 17 16 — 1 3 46 34 — 0 1 5 —
Nebraska† — 0 4 8 18 — 0 2 10 15 — 0 1 2 2
North Dakota — 0 1 — — — 0 0 — — — 0 1 — —
South Dakota — 0 0 — 3 — 0 1 1 3 — 0 0 — 1
S. Atlantic 7 8 14 258 311 10 16 40 622 654 8 4 7 133 122
Delaware — 0 1 6 3 — 0 2 19 23 U 0 0 U U
District of Columbia — 0 1 1 1 — 0 1 3 9 — 0 1 2 1
Florida 3 3 8 98 136 3 6 12 221 214 6 1 4 47 32
Georgia 1 1 3 30 35 — 3 7 103 110 — 0 2 6 29
Maryland† 2 0 4 22 32 2 1 6 46 58 — 0 2 19 17
North Carolina 1 0 5 42 34 5 1 15 70 85 2 1 3 35 16
South Carolina† — 1 4 22 44 — 1 4 39 39 — 0 0 — 1
Virginia† — 1 6 35 25 — 2 14 73 67 — 0 2 10 7
West Virginia — 0 2 2 1 — 0 14 48 49 — 0 5 14 19
E.S. Central 1 1 3 31 32 1 7 13 240 239 2 3 7 100 71
Alabama† — 0 1 5 7 — 1 5 43 69 — 0 2 5 5
Kentucky — 0 2 13 8 — 2 7 82 57 — 2 5 67 42
Mississippi — 0 1 2 8 — 1 3 24 21 U 0 0 U U
Tennessee† 1 0 2 11 9 1 3 7 91 92 2 1 4 28 24
W.S. Central 2 2 19 85 137 28 10 109 337 411 1 1 14 52 43
Arkansas† — 0 3 — 7 — 0 4 32 50 — 0 1 — 1
Louisiana — 0 2 6 4 — 1 4 34 49 — 0 1 4 6
Oklahoma — 0 3 — 3 3 1 19 69 75 — 0 12 18 12
Texas† 2 2 18 79 123 25 5 87 202 237 1 1 3 30 24
Mountain 1 3 8 112 120 1 2 8 88 103 — 1 5 36 36
Arizona 1 1 5 51 51 — 0 2 22 37 U 0 0 U U
Colorado — 1 3 25 39 — 0 3 19 19 — 0 2 6 23
Idaho† — 0 2 6 3 — 0 1 6 9 — 0 2 8 2
Montana† — 0 1 4 6 — 0 1 1 — — 0 0 — 1
Nevada† — 0 2 12 9 1 0 3 32 25 — 0 1 3 2
New Mexico† — 0 1 3 7 — 0 1 3 5 — 0 2 9 5
Utah — 0 2 8 3 — 0 1 5 4 — 0 2 10 3
Wyoming† — 0 3 3 2 — 0 0 — 4 — 0 0 — —
Pacific 3 5 16 173 243 1 6 20 206 240 3 1 6 50 59
Alaska — 0 1 1 2 — 0 1 2 2 U 0 2 U U
California 3 4 15 140 191 — 4 17 142 171 1 0 4 22 31
Hawaii — 0 2 2 8 — 0 1 1 5 U 0 0 U U
Oregon — 0 2 15 11 — 1 4 30 29 — 0 3 10 15
Washington — 0 2 15 31 1 1 4 31 33 2 0 6 18 13
Territories
American Samoa — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 6 14 4 — 1 6 31 48 — 0 6 26 37
Puerto Rico — 0 1 3 20 — 0 5 10 21 — 0 0 — —
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending September 18, 2010, and September 19, 2009 (37th week)*
Reporting area
Legionellosis Lyme disease Malaria
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 34 60 111 2,072 2,381 265 420 2,336 18,951 29,907 25 24 89 964 1,018
New England 2 3 10 140 155 30 123 411 5,436 10,488 — 1 4 51 44
Connecticut 2 0 4 31 45 — 39 191 1,863 3,624 — 0 1 1 5
Maine† — 0 1 8 6 28 12 76 506 630 — 0 1 5 2
Massachusetts — 1 7 77 77 1 41 161 1,876 4,562 — 1 3 37 27
New Hampshire — 0 3 11 10 — 21 59 905 1,140 — 0 1 2 4
Rhode Island† — 0 3 5 10 — 0 11 36 201 — 0 1 4 3
Vermont† — 0 2 8 7 1 4 26 250 331 — 0 1 2 3
Mid. Atlantic 14 16 42 523 877 125 189 665 9,096 12,935 6 7 15 258 298
New Jersey — 2 8 51 165 — 44 173 2,202 4,300 — 0 4 1 78
New York (Upstate) 8 5 19 180 263 90 55 577 2,205 2,976 6 1 4 57 37
New York City — 2 12 84 177 — 2 31 31 844 — 4 10 161 140
Pennsylvania 6 6 16 208 272 35 75 365 4,658 4,815 — 1 3 39 43
E.N. Central 3 11 33 459 513 1 21 135 1,350 2,588 — 2 9 97 140
Illinois — 1 10 75 89 — 1 11 73 127 — 1 7 33 59
Indiana — 1 6 69 43 — 1 7 61 73 — 0 2 7 20
Michigan — 3 18 111 113 1 1 14 85 83 — 0 4 21 21
Ohio 3 4 12 161 206 — 0 5 22 39 — 0 5 31 31
Wisconsin — 1 11 43 62 — 18 116 1,109 2,266 — 0 1 5 9
W.N. Central 1 2 19 82 84 4 2 1,395 95 193 2 1 11 52 44
Iowa — 0 2 11 20 — 0 10 67 101 — 0 1 8 10
Kansas — 0 2 6 5 — 0 1 5 17 — 0 2 8 6
Minnesota — 0 16 23 8 — 0 1,380 — 68 — 0 11 3 13
Missouri 1 0 4 25 40 — 0 1 1 3 1 0 3 17 9
Nebraska† — 0 2 8 9 — 0 2 9 3 1 0 2 14 5
North Dakota — 0 1 4 1 4 0 15 12 — — 0 1 — —
South Dakota — 0 1 5 1 — 0 1 1 1 — 0 2 2 1
S. Atlantic 8 11 25 379 360 97 56 163 2,681 3,359 9 6 36 257 269
Delaware — 0 3 12 12 — 12 31 486 801 — 0 1 2 4
District of Columbia — 0 4 12 15 — 0 4 18 49 — 0 3 7 12
Florida 6 4 10 132 119 11 2 11 73 57 3 2 7 93 75
Georgia — 1 4 32 34 — 0 2 8 36 — 0 2 3 57
Maryland† 1 3 12 85 92 12 26 73 1,099 1,658 3 1 19 62 57
North Carolina — 1 7 40 42 — 1 9 67 78 2 0 13 35 20
South Carolina† — 0 2 9 6 — 1 3 26 26 — 0 1 3 3
Virginia† 1 1 6 47 34 74 15 79 818 555 1 1 5 50 39
West Virginia — 0 3 10 6 — 0 33 86 99 — 0 2 2 2
E.S. Central 1 2 10 94 98 — 1 4 37 28 — 0 3 22 28
Alabama† — 0 2 10 13 — 0 1 1 2 — 0 1 4 8
Kentucky 1 0 4 21 40 — 0 1 3 1 — 0 3 6 8
Mississippi — 0 3 9 4 — 0 0 — — — 0 2 2 3
Tennessee† — 1 6 54 41 — 1 4 33 25 — 0 2 10 9
W.S. Central — 3 14 95 76 3 3 44 72 151 2 1 31 60 46
Arkansas† — 0 2 11 6 — 0 0 — — — 0 1 1 3
Louisiana — 0 3 5 7 — 0 1 2 — — 0 1 2 5
Oklahoma — 0 4 11 3 — 0 2 — — — 0 1 5 1
Texas† — 2 10 68 60 3 3 42 70 151 2 1 30 52 37
Mountain 3 3 10 114 94 — 0 3 17 47 1 1 3 44 43
Arizona 1 1 5 36 34 — 0 1 3 4 — 0 2 19 8
Colorado — 1 5 25 14 — 0 1 2 1 — 0 2 14 24
Idaho† 2 0 1 6 4 — 0 1 5 13 — 0 1 1 2
Montana† — 0 1 4 5 — 0 1 1 3 — 0 1 2 5
Nevada† — 0 2 18 11 — 0 1 — 12 1 0 1 4 —
New Mexico† — 0 2 6 5 — 0 2 4 4 — 0 1 1 —
Utah — 0 3 15 20 — 0 1 2 8 — 0 1 3 4
Wyoming† — 0 2 4 1 — 0 1 — 2 — 0 0 — —
Pacific 2 5 19 186 124 5 4 10 167 118 5 3 19 123 106
Alaska — 0 2 2 1 — 0 1 4 5 — 0 1 2 2
California 2 3 19 159 97 5 3 8 113 76 2 2 13 83 79
Hawaii — 0 1 1 1 N 0 0 N N — 0 1 1 1
Oregon — 0 3 10 10 — 1 3 43 30 1 0 1 9 10
Washington — 0 4 14 15 — 0 3 7 7 2 0 5 28 14
Territories
American Samoa — 0 0 — — N 0 0 N N — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 0 — — — 0 0 — — — 0 0 — —
Puerto Rico — 0 1 — 1 N 0 0 N N — 0 1 2 4
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending September 18, 2010, and September 19, 2009 (37th week)*
Reporting area
Meningococcal disease, invasive† 
All groups Pertussis Rabies, animal
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 5 16 43 537 689 211 289 1,756 12,043 11,313 25 72 145 2,517 3,861
New England — 0 2 13 25 2 8 20 303 498 2 4 24 171 246
Connecticut — 0 2 2 3 — 1 8 70 38 — 0 22 59 101
Maine§ — 0 1 3 4 1 0 5 29 72 — 1 4 45 41
Massachusetts — 0 1 3 12 1 4 11 164 291 — 0 0 — —
New Hampshire — 0 1 — 1 — 0 3 10 62 — 0 5 11 25
Rhode Island§ — 0 0 — 4 — 0 8 22 26 — 0 2 14 35
Vermont§ — 0 1 5 1 — 0 3 8 9 2 1 5 42 44
Mid. Atlantic — 1 4 44 77 29 21 63 904 860 10 17 41 764 441
New Jersey — 0 2 9 13 — 3 8 73 176 — 0 0 — —
New York (Upstate) — 0 3 9 17 15 7 27 333 148 10 9 22 389 328
New York City — 0 2 11 13 5 0 11 49 59 — 2 12 112 13
Pennsylvania — 0 2 15 34 9 9 39 449 477 — 5 24 263 100
E.N. Central — 3 8 93 123 61 68 160 3,082 2,360 2 2 38 253 201
Illinois — 0 4 17 31 — 11 29 493 521 2 1 22 155 75
Indiana — 0 3 21 28 — 9 26 395 268 — 0 0 — 25
Michigan — 0 2 13 18 12 22 45 858 607 — 1 5 56 59
Ohio — 1 2 23 28 49 20 69 1,068 829 — 0 12 42 42
Wisconsin — 0 2 19 18 — 6 15 268 135 — 0 0 — —
W.N. Central 1 1 6 39 52 23 27 627 1,327 1,667 1 5 16 190 304
Iowa — 0 3 8 7 — 6 25 287 171 — 0 2 7 26
Kansas — 0 2 6 9 1 3 9 114 190 1 1 4 49 64
Minnesota — 0 2 2 10 5 0 601 468 336 — 0 9 26 44
Missouri — 0 3 16 18 6 8 25 255 808 — 1 6 56 55
Nebraska§ — 0 2 5 5 5 2 12 140 112 — 1 4 43 69
North Dakota 1 0 1 2 1 6 0 30 38 17 — 0 7 9 4
South Dakota — 0 2 — 2 — 1 5 25 33 — 0 2 — 42
S. Atlantic 1 3 7 106 126 17 26 77 1,065 1,254 7 22 85 781 1,627
Delaware — 0 1 1 2 — 0 4 9 10 — 0 0 — —
District of Columbia — 0 0 — — — 0 1 4 4 — 0 0 — —
Florida 1 1 5 49 40 2 5 28 232 414 — 0 72 72 161
Georgia — 0 2 9 25 1 3 17 169 188 — 0 13 — 307
Maryland§ — 0 1 5 8 — 2 8 83 106 4 6 15 260 302
North Carolina — 0 2 14 24 — 1 32 124 159 — 0 15 — 367
South Carolina§ — 0 1 9 11 4 5 19 261 199 — 0 0 — —
Virginia§ — 0 2 17 11 2 4 15 138 150 — 10 26 393 403
West Virginia — 0 2 2 5 8 0 7 45 24 3 1 6 56 87
E.S. Central — 1 4 27 23 7 14 29 530 644 — 3 7 120 113
Alabama§ — 0 2 5 6 — 4 8 147 249 — 0 4 38 —
Kentucky — 0 2 12 4 7 4 13 184 191 — 0 4 16 37
Mississippi — 0 1 3 3 — 1 6 46 54 — 0 1 1 4
Tennessee§ — 0 2 7 10 — 4 10 153 150 — 1 4 65 72
W.S. Central 3 1 9 63 64 43 57 753 2,009 2,353 1 1 40 61 647
Arkansas§ — 0 2 5 5 — 4 29 118 273 1 0 10 21 28
Louisiana — 0 4 12 13 — 1 4 24 129 — 0 0 — —
Oklahoma — 0 7 14 8 3 0 41 42 37 — 0 30 40 21
Texas§ 3 0 7 32 38 40 49 681 1,825 1,914 — 0 30 — 598
Mountain — 1 6 44 50 15 21 41 810 719 2 1 8 57 82
Arizona — 0 2 11 12 1 6 14 257 177 — 0 5 — —
Colorado — 0 4 13 15 — 3 13 142 183 — 0 0 — —
Idaho§ — 0 2 7 6 14 2 19 141 66 2 0 2 9 5
Montana§ — 0 1 1 5 — 1 8 43 31 — 0 3 14 24
Nevada§ — 0 1 8 4 — 0 7 22 19 — 0 1 4 5
New Mexico§ — 0 1 3 3 — 1 8 61 52 — 0 3 9 21
Utah — 0 1 1 1 — 4 10 138 169 — 0 2 2 8
Wyoming§ — 0 1 — 4 — 0 1 6 22 — 0 4 19 19
Pacific — 3 16 108 149 14 34 186 2,013 958 — 3 12 120 200
Alaska — 0 1 1 6 — 0 6 28 35 — 0 2 11 11
California — 1 13 70 96 — 22 162 1,466 469 — 2 12 99 178
Hawaii — 0 1 1 5 — 0 6 31 32 — 0 0 — —
Oregon — 1 3 24 29 — 5 16 247 210 — 0 2 10 11
Washington — 0 7 12 13 14 4 24 241 212 — 0 0 — —
Territories
American Samoa — 0 0 — — — 0 0 — — N 0 0 N N
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 0 — — — 0 2 — — — 0 0 — —
Puerto Rico — 0 1 — — — 0 0 — 1 1 1 3 33 29
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Data for meningococcal disease, invasive caused by serogroups A, C, Y, and W-135; serogroup B; other serogroup; and unknown serogroup are available in Table I.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending September 18, 2010, and September 19, 2009 (37th week)*
Reporting area
Salmonellosis Shiga toxin-producing E. coli (STEC)† Shigellosis
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 887 902 1,648 32,958 33,881 81 79 198 3,164 3,308 205 259 527 9,404 11,665
New England 3 29 380 1,673 1,789 1 3 43 149 198 1 5 53 248 279
Connecticut — 0 364 364 430 — 0 43 43 67 — 0 47 47 43
Maine§ 1 2 7 89 102 — 0 2 14 14 — 0 2 5 3
Massachusetts 1 21 48 945 880 — 2 8 62 71 1 4 16 179 193
New Hampshire — 3 10 127 222 — 0 2 17 26 — 0 2 7 16
Rhode Island§ — 2 17 97 101 — 0 26 2 1 — 0 3 9 19
Vermont§ 1 1 5 51 54 1 0 2 11 19 — 0 1 1 5
Mid. Atlantic 84 95 207 4,044 4,034 13 8 28 369 324 8 34 61 1,202 2,237
New Jersey — 18 48 701 868 — 1 4 38 80 — 6 17 221 490
New York (Upstate) 63 24 78 1,042 934 9 3 15 147 100 3 4 19 165 165
New York City 4 25 56 961 931 — 1 6 53 48 — 7 13 220 340
Pennsylvania 17 29 80 1,340 1,301 4 2 13 131 96 5 17 35 596 1,242
E.N. Central 31 80 232 3,645 3,939 8 12 35 517 575 5 25 235 1,203 2,095
Illinois — 25 113 1,225 1,106 — 1 8 76 137 — 8 228 646 489
Indiana — 10 53 369 466 — 1 8 67 72 — 1 5 31 56
Michigan 7 15 41 656 751 5 3 16 135 109 2 4 9 172 179
Ohio 24 24 47 995 1,083 3 2 11 115 103 3 7 23 239 940
Wisconsin — 10 40 400 533 — 3 11 124 154 — 3 14 115 431
W.N. Central 37 44 94 1,781 2,031 10 10 39 467 568 10 48 88 1,692 710
Iowa 3 7 35 384 320 — 2 16 127 132 — 1 5 40 46
Kansas 6 7 18 326 309 — 1 6 50 49 4 4 14 193 162
Minnesota — 2 32 178 434 — 0 14 31 148 — 0 5 14 59
Missouri 23 12 44 588 487 6 3 27 183 102 6 42 75 1,412 411
Nebraska§ 3 4 13 177 287 4 1 6 55 72 — 0 4 27 25
North Dakota 2 0 39 29 35 — 0 7 — 4 — 0 5 — 3
South Dakota — 2 7 99 159 — 0 4 21 61 — 0 2 6 4
S. Atlantic 362 267 553 9,443 9,158 13 13 30 490 484 62 40 85 1,647 1,789
Delaware — 3 11 117 90 — 0 2 4 11 — 1 10 37 87
District of Columbia — 2 4 52 71 — 0 1 5 2 — 0 4 20 18
Florida 223 127 277 4,011 3,900 9 4 13 170 119 28 13 49 725 325
Georgia 86 40 128 1,686 1,680 1 1 15 75 53 27 13 25 507 471
Maryland§ 24 15 52 739 565 1 2 6 65 70 3 3 8 88 310
North Carolina 14 29 144 1,062 1,300 — 1 7 44 81 — 2 17 117 328
South Carolina§ 6 20 77 913 663 — 0 3 16 24 — 1 5 50 95
Virginia§ 8 18 68 729 731 2 2 15 97 105 4 3 15 102 149
West Virginia 1 3 16 134 158 — 0 5 14 19 — 0 2 1 6
E.S. Central 28 50 147 2,290 2,198 1 4 11 172 167 2 11 40 486 616
Alabama§ — 14 42 548 609 — 1 4 36 39 — 3 10 104 117
Kentucky 13 8 29 383 353 — 1 6 41 57 — 4 28 184 145
Mississippi 1 14 61 713 667 — 0 2 11 6 — 1 4 32 37
Tennessee§ 14 14 46 646 569 1 2 8 84 65 2 4 11 166 317
W.S. Central 163 114 547 3,749 3,895 7 5 68 196 218 48 46 251 1,660 2,191
Arkansas§ 29 10 38 485 437 2 1 5 42 27 1 1 9 39 245
Louisiana 10 21 45 762 806 — 0 2 12 20 — 4 12 169 150
Oklahoma 40 10 46 444 454 — 0 27 15 23 10 6 96 209 208
Texas§ 84 73 477 2,058 2,198 5 3 41 127 148 37 34 144 1,243 1,588
Mountain 10 48 104 1,898 2,274 4 9 30 401 436 11 15 39 516 878
Arizona — 18 41 625 760 1 1 5 43 47 5 8 25 271 632
Colorado — 11 23 421 481 — 2 18 144 136 — 2 6 82 73
Idaho§ 1 3 9 118 140 1 1 7 57 65 1 0 3 19 7
Montana§ 2 2 7 69 88 2 0 5 30 27 — 0 1 6 11
Nevada§ 7 4 20 221 197 — 0 5 25 25 5 0 7 27 53
New Mexico§ — 5 15 199 289 — 1 4 31 30 — 2 9 82 85
Utah — 5 18 212 249 — 1 7 60 94 — 0 4 29 15
Wyoming§ — 1 9 33 70 — 0 2 11 12 — 0 2 — 2
Pacific 169 115 299 4,435 4,563 24 9 46 403 338 58 20 64 750 870
Alaska — 1 5 64 54 — 0 1 2 1 — 0 2 1 2
California 128 84 227 3,344 3,380 11 5 35 173 170 49 16 51 618 694
Hawaii 7 4 14 128 252 — 0 4 18 4 1 0 3 12 31
Oregon 6 8 48 400 330 — 2 11 71 49 1 1 4 39 40
Washington 28 14 61 499 547 13 3 19 139 114 7 1 22 80 103
Territories
American Samoa — 1 1 2 — — 0 0 — — 1 0 1 2 3
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 2 4 9 — 0 0 — — — 0 3 1 7
Puerto Rico 3 5 39 156 401 — 0 0 — — — 0 1 — 10
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Includes E. coli O157:H7; Shiga toxin-positive, serogroup non-O157; and Shiga toxin-positive, not serogrouped.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending September 18, 2010, and September 19, 2009 (37th week)*











Previous 52 weeks Cum  
2010
Cum  
2009Med Max Med Max
United States 5 2 12 119 122 22 15 421 1,035 1,120
New England — 0 0 — 2 — 0 1 1 9
Connecticut — 0 0 — — — 0 0 — —
Maine§ — 0 0 — — — 0 1 1 4
Massachusetts — 0 0 — 1 — 0 1 — 5
New Hampshire — 0 0 — — — 0 1 — —
Rhode Island§ — 0 0 — — — 0 0 — —
Vermont§ — 0 0 — 1 — 0 0 — —
Mid. Atlantic — 0 2 15 10 1 1 4 43 84
New Jersey — 0 0 — 2 — 0 3 — 54
New York (Upstate) — 0 1 2 — 1 0 3 12 11
New York City — 0 1 1 1 — 0 4 21 6
Pennsylvania — 0 2 12 7 — 0 1 10 13
E.N. Central — 0 1 4 8 — 1 8 65 76
Illinois — 0 1 2 1 — 0 5 19 46
Indiana — 0 1 2 3 — 0 5 34 9
Michigan — 0 1 — 3 — 0 2 3 1
Ohio — 0 0 — — — 0 2 8 16
Wisconsin — 0 0 — 1 — 0 1 1 4
W.N. Central — 0 3 13 17 2 2 20 222 239
Iowa — 0 0 — 1 — 0 1 3 4
Kansas — 0 1 2 1 — 0 0 — —
Minnesota — 0 1 — 1 — 0 1 — 1
Missouri — 0 3 10 7 2 2 19 214 230
Nebraska§ — 0 1 1 7 — 0 1 4 4
North Dakota — 0 0 — — — 0 1 1 —
South Dakota — 0 0 — — — 0 0 — —
S. Atlantic 1 1 9 59 59 11 5 59 349 336
Delaware — 0 1 1 — — 0 3 15 16
District of Columbia — 0 0 — — — 0 1 — —
Florida — 0 1 2 — — 0 1 7 4
Georgia 1 0 6 39 47 — 0 0 — —
Maryland§ — 0 1 2 3 3 0 4 32 34
North Carolina — 0 3 11 6 8 1 48 194 219
South Carolina§ — 0 1 1 3 — 0 2 10 15
Virginia§ — 0 2 3 — — 1 10 91 46
West Virginia — 0 0 — — — 0 0 — 2
E.S. Central 1 0 3 15 7 3 3 28 288 232
Alabama§ — 0 1 4 3 — 1 8 54 58
Kentucky — 0 2 6 1 — 0 0 — —
Mississippi — 0 0 — — — 0 2 7 9
Tennessee§ 1 0 2 5 3 3 2 20 227 165
W.S. Central 3 0 3 4 6 4 1 408 58 121
Arkansas§ — 0 1 — — — 0 110 20 62
Louisiana — 0 0 — — — 0 1 2 2
Oklahoma 3 0 2 3 5 4 0 287 21 39
Texas§ — 0 1 1 1 — 0 11 15 18
Mountain — 0 2 2 12 1 0 2 8 23
Arizona — 0 2 — 6 — 0 1 2 11
Colorado — 0 0 — 1 1 0 0 1 —
Idaho§ — 0 0 — — — 0 1 2 1
Montana§ — 0 1 2 4 — 0 1 1 6
Nevada§ — 0 0 — — — 0 0 — 1
New Mexico§ — 0 0 — — — 0 1 1 1
Utah — 0 0 — — — 0 1 1 1
Wyoming§ — 0 0 — 1 — 0 0 — 2
Pacific — 0 2 7 1 — 0 1 1 —
Alaska N 0 0 N N N 0 0 N N
California — 0 2 6 1 — 0 0 — —
Hawaii N 0 0 N N N 0 0 N N
Oregon — 0 1 1 — — 0 1 1 —
Washington — 0 0 — — — 0 0 — —
Territories
American Samoa N 0 0 N N N 0 0 N N
C.N.M.I. — — — — — — — — — —
Guam N 0 0 N N N 0 0 N N
Puerto Rico N 0 0 N N N 0 0 N N
U.S. Virgin Islands — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Illnesses with similar clinical presentation that result from Spotted fever group rickettsia infections are reported as Spotted fever rickettsioses. Rocky Mountain spotted fever (RMSF) caused 
by Rickettsia rickettsii, is the most common and well-known spotted fever.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending September 18, 2010, and September 19, 2009 (37th week)*
Streptococcus pneumoniae,† invasive disease
Reporting area
All ages Age <5 Syphilis, primary and secondary
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 97 189 492 10,264 2,151 13 51 156 1,597 1,664 71 237 413 8,098 10,105
New England — 7 99 567 40 — 1 24 76 51 5 8 22 318 232
Connecticut — 0 92 254 — — 0 22 24 — — 1 10 65 44
Maine§ — 2 6 89 11 — 0 2 7 4 3 0 3 19 2
Massachusetts — 0 5 54 3 — 1 4 37 36 2 5 15 190 163
New Hampshire — 0 7 59 — — 0 2 3 8 — 0 1 14 13
Rhode Island§ — 0 34 53 15 — 0 2 2 1 — 0 4 28 10
Vermont§ — 1 6 58 11 — 0 1 3 2 — 0 2 2 —
Mid. Atlantic 12 15 54 886 131 1 7 48 247 214 37 33 45 1,214 1,282
New Jersey — 1 8 78 — — 1 5 39 38 7 4 12 165 166
New York (Upstate) 3 3 12 118 53 — 3 19 84 93 2 2 11 99 87
New York City 4 4 25 334 8 1 1 24 84 70 21 18 31 698 791
Pennsylvania 5 6 22 356 70 — 0 5 40 13 7 7 16 252 238
E.N. Central 12 31 98 2,058 487 1 8 18 257 277 2 27 46 935 1,114
Illinois — 1 7 70 — — 2 5 63 43 — 12 23 319 541
Indiana — 7 23 420 192 — 1 6 36 59 — 3 13 126 117
Michigan 1 7 27 482 20 1 2 6 58 51 — 3 12 153 175
Ohio 9 14 49 846 275 — 2 6 68 94 2 8 16 308 246
Wisconsin 2 5 22 240 — — 1 4 32 30 — 1 3 29 35
W.N. Central 3 8 182 589 142 — 2 12 104 136 2 5 15 213 230
Iowa — 0 0 — — — 0 0 — — — 0 2 9 17
Kansas — 1 7 72 47 — 0 2 11 15 — 0 3 12 24
Minnesota — 0 179 287 35 — 0 10 44 61 — 1 9 81 53
Missouri — 2 10 83 50 — 0 3 28 38 2 3 8 105 128
Nebraska§ 2 1 7 93 1 — 0 2 12 10 — 0 1 6 5
North Dakota 1 0 11 40 7 — 0 1 2 4 — 0 1 — 3
South Dakota — 0 3 14 2 — 0 2 7 8 — 0 0 — —
S. Atlantic 34 40 144 2,395 964 5 12 28 398 398 7 56 218 1,929 2,416
Delaware — 0 3 27 15 — 0 2 — — — 0 2 4 23
District of Columbia — 0 4 21 17 — 0 2 7 3 — 2 8 94 128
Florida 22 18 89 1,105 565 2 3 18 148 141 2 19 33 702 755
Georgia 6 10 28 398 276 2 4 12 108 104 — 10 167 371 574
Maryland§ 5 6 25 347 4 1 1 6 40 61 — 6 11 191 209
North Carolina — 0 0 — — — 0 0 — — 4 7 31 263 406
South Carolina§ 1 5 25 366 — — 1 4 40 37 1 2 7 103 92
Virginia§ — 0 4 41 — — 1 4 39 34 — 4 22 198 225
West Virginia — 1 21 90 87 — 0 4 16 18 — 0 2 3 4
E.S. Central 12 19 50 916 207 2 2 8 90 106 4 18 39 631 832
Alabama§ — 0 0 — — — 0 0 — — 2 5 12 168 328
Kentucky 6 2 16 143 56 2 0 2 13 7 — 2 13 92 47
Mississippi — 1 6 43 37 — 0 2 9 20 — 5 17 149 157
Tennessee§ 6 12 44 730 114 — 1 7 68 79 2 6 17 222 300
W.S. Central 14 17 91 1,329 93 4 5 41 216 247 2 34 71 1,080 2,054
Arkansas§ 1 2 9 123 43 — 0 3 11 33 — 3 14 112 177
Louisiana — 1 8 62 50 — 0 3 19 20 — 0 23 64 600
Oklahoma 2 0 5 38 — 2 1 5 38 43 2 1 6 55 66
Texas§ 11 14 83 1,106 — 2 3 34 148 151 — 25 42 849 1,211
Mountain 8 20 82 1,303 84 — 5 12 181 210 1 9 20 309 393
Arizona 7 7 51 609 — — 2 7 78 96 — 3 7 92 181
Colorado — 6 20 380 — — 1 4 51 30 — 2 5 76 69
Idaho§ — 0 2 11 — — 0 2 5 7 — 0 1 2 3
Montana§ — 0 2 13 — — 0 1 1 — — 0 1 1 —
Nevada§ 1 1 4 56 34 — 0 1 5 7 1 1 10 75 74
New Mexico§ — 2 9 115 — — 0 4 14 24 — 1 4 32 41
Utah — 2 9 110 41 — 1 4 24 45 — 1 4 31 22
Wyoming§ — 0 1 9 9 — 0 1 3 1 — 0 0 — 3
Pacific 2 4 14 221 3 — 0 7 28 25 11 40 60 1,469 1,552
Alaska — 1 9 84 — — 0 5 18 16 — 0 1 1 —
California 2 3 12 137 — — 0 2 10 — 11 37 55 1,300 1,378
Hawaii — 0 0 — 3 — 0 1 — 9 — 0 3 25 26
Oregon — 0 0 — — — 0 0 — — — 0 5 6 42
Washington — 0 0 — — — 0 0 — — — 3 10 137 106
Territories
American Samoa — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 0 — — — 0 0 — — — 0 0 — —
Puerto Rico — 0 0 — — — 0 0 — — 6 3 15 167 163
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Includes drug resistant and susceptible cases of invasive Streptococcus pneumoniae disease among children <5 years and among all ages. Case definition: Isolation of S. pneumoniae from 
a normally sterile body site (e.g., blood or cerebrospinal fluid).
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending September 18, 2010, and September 19, 2009 (37th week)*
West Nile virus disease†
Reporting area
Varicella (chickenpox)§ Neuroinvasive Nonneuroinvasive¶
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 140 326 548 10,143 15,537 1 0 52 262 355 — 1 33 203 306
New England 1 15 36 476 774 — 0 3 8 — — 0 2 3 —
Connecticut — 6 20 220 373 — 0 2 5 — — 0 2 3 —
Maine§ — 3 15 130 142 — 0 0 — — — 0 0 — —
Massachusetts — 0 1 — 3 — 0 2 3 — — 0 0 — —
New Hampshire — 2 8 92 151 — 0 0 — — — 0 0 — —
Rhode Island§ 1 1 12 22 27 — 0 0 — — — 0 0 — —
Vermont§ — 0 10 12 78 — 0 0 — — — 0 0 — —
Mid. Atlantic 19 34 66 1,146 1,543 — 0 15 73 6 — 0 6 26 1
New Jersey — 9 30 407 321 — 0 2 8 3 — 0 1 3 —
New York (Upstate) N 0 0 N N — 0 8 35 2 — 0 6 17 1
New York City — 0 0 — — — 0 5 23 1 — 0 4 5 —
Pennsylvania 19 22 52 739 1,222 — 0 3 7 — — 0 1 1 —
E.N. Central 27 108 176 3,374 4,816 — 0 6 14 9 — 0 4 9 4
Illinois 5 26 49 889 1,169 — 0 2 3 5 — 0 1 2 —
Indiana§ — 5 35 303 360 — 0 0 — 2 — 0 2 3 2
Michigan 6 35 62 1,016 1,369 — 0 4 10 1 — 0 1 2 —
Ohio 16 28 56 925 1,466 — 0 1 1 — — 0 1 1 2
Wisconsin — 7 21 241 452 — 0 0 — 1 — 0 1 1 —
W.N. Central 10 15 40 555 1,027 — 0 7 22 24 — 0 8 49 65
Iowa N 0 0 N N — 0 1 1 — — 0 1 2 5
Kansas§ — 6 22 209 431 — 0 0 — 4 — 0 2 5 8
Minnesota — 0 0 — — — 0 1 3 1 — 0 1 — 2
Missouri 8 6 23 290 498 — 0 1 3 3 — 0 1 — —
Nebraska§ N 0 0 N N — 0 3 9 10 — 0 4 20 36
North Dakota 1 0 26 32 57 — 0 2 2 — — 0 1 6 1
South Dakota 1 0 7 24 41 — 0 2 4 6 — 0 3 16 13
S. Atlantic 46 37 99 1,568 1,942 1 0 3 14 15 — 0 3 8 2
Delaware§ — 0 4 21 11 — 0 0 — — — 0 0 — —
District of Columbia — 0 4 15 26 — 0 0 — 2 — 0 0 — —
Florida§ 27 15 57 783 945 1 0 2 5 1 — 0 1 1 1
Georgia N 0 0 N N — 0 1 3 4 — 0 2 6 —
Maryland§ N 0 0 N N — 0 3 6 — — 0 1 1 1
North Carolina N 0 0 N N — 0 0 — — — 0 0 — —
South Carolina§ — 0 35 75 93 — 0 0 — 3 — 0 0 — —
Virginia§ 11 11 34 352 533 — 0 1 — 5 — 0 0 — —
West Virginia 8 8 26 322 334 — 0 0 — — — 0 0 — —
E.S. Central 3 6 28 215 409 — 0 5 3 34 — 0 3 5 24
Alabama§ 3 6 27 208 406 — 0 1 1 — — 0 1 2 —
Kentucky N 0 0 N N — 0 1 — 3 — 0 0 — —
Mississippi — 0 2 7 3 — 0 2 2 27 — 0 2 3 19
Tennessee§ N 0 0 N N — 0 2 — 4 — 0 1 — 5
W.S. Central 30 55 285 2,020 3,901 — 0 9 38 111 — 0 3 11 32
Arkansas§ — 3 32 122 403 — 0 3 3 6 — 0 0 — —
Louisiana — 1 5 40 111 — 0 2 9 10 — 0 1 6 9
Oklahoma N 0 0 N N — 0 2 — 7 — 0 0 — 2
Texas§ 30 47 272 1,858 3,387 — 0 9 26 88 — 0 2 5 21
Mountain 4 21 37 751 1,039 — 0 10 66 76 — 0 10 71 117
Arizona — 0 0 — — — 0 10 52 12 — 0 9 36 6
Colorado§ 4 8 19 300 401 — 0 4 10 35 — 0 6 28 65
Idaho§ N 0 0 N N — 0 0 — 9 — 0 2 — 27
Montana§ — 3 17 158 126 — 0 0 — 2 — 0 0 — 3
Nevada§ N 0 0 N N — 0 0 — 7 — 0 1 2 5
New Mexico§ — 2 8 83 97 — 0 1 3 6 — 0 2 3 2
Utah — 6 22 197 415 — 0 0 — 1 — 0 0 — 1
Wyoming§ — 0 3 13 — — 0 1 1 4 — 0 1 2 8
Pacific — 1 5 38 86 — 0 10 24 80 — 0 4 21 61
Alaska — 0 5 31 52 — 0 0 — — — 0 0 — —
California — 0 0 — — — 0 8 24 53 — 0 4 21 39
Hawaii — 0 2 7 34 — 0 0 — — — 0 0 — —
Oregon N 0 0 N N — 0 0 — 1 — 0 1 — 10
Washington N 0 0 N N — 0 2 — 26 — 0 0 — 12
Territories
American Samoa N 0 0 N N — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 3 12 17 — 0 0 — — — 0 0 — —
Puerto Rico 3 5 30 207 423 — 0 0 — — — 0 0 — —
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional. Data for HIV/AIDS, AIDS, and TB, when available, are displayed in Table IV, which appears quarterly.
† Updated weekly from reports to the Division of Vector-Borne Infectious Diseases, National Center for Zoonotic, Vector-Borne, and Enteric Diseases (ArboNET Surveillance). Data for California 
serogroup, eastern equine, Powassan, St. Louis, and western equine diseases are available in Table I.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
¶ Not reportable in all states. Data from states where the condition is not reportable are excluded from this table, except starting in 2007 for the domestic arboviral diseases and influenza-
associated pediatric mortality, and in 2003 for SARS-CoV. Reporting exceptions are available at http://www.cdc.gov/ncphi/disss/nndss/phs/infdis.htm.
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TABLE III. Deaths in 122 U.S. cities,* week ending September 18, 2010 (37th week)
Reporting area
All causes, by age (years)
P&I† 
Total Reporting area




Ages ≥65 45–64 25–44 1–24 <1
All  
Ages ≥65 45–64 25–44 1–24 <1
New England 491 335 102 30 11 13 41 S. Atlantic 1,228 756 327 91 26 28 76
Boston, MA 119 67 33 7 8 4 7 Atlanta, GA 115 65 31 14 4 1 6
Bridgeport, CT 23 15 4 4 — — 3 Baltimore, MD 147 75 47 15 7 3 18
Cambridge, MA 14 12 2 — — — — Charlotte, NC 152 99 39 9 2 3 6
Fall River, MA 24 19 4 1 — — — Jacksonville, FL 137 83 34 15 2 3 8
Hartford, CT 68 50 14 3 1 — 7 Miami, FL 145 97 34 7 6 1 5
Lowell, MA 23 17 5 1 — — 3 Norfolk, VA 45 27 10 4 2 2 —
Lynn, MA 11 7 2 1 1 — — Richmond, VA 63 37 21 4 — 1 6
New Bedford, MA 14 12 2 — — — — Savannah, GA 61 42 17 2 — — 3
New Haven, CT 33 23 8 2 — — 3 St. Petersburg, FL 48 27 14 1 1 5 —
Providence, RI 46 33 11 1 — 1 4 Tampa, FL 198 132 49 13 1 3 13
Somerville, MA U U U U U U U Washington, D.C. 103 62 30 4 1 6 10
Springfield, MA 36 24 5 5 1 1 1 Wilmington, DE 14 10 1 3 — — 1
Waterbury, CT 23 17 4 2 — — 5 E.S. Central 865 528 227 51 24 25 68
Worcester, MA 57 39 8 3 — 7 8 Birmingham, AL 174 99 56 11 4 4 16
Mid. Atlantic 1,743 1,184 414 79 40 25 79 Chattanooga, TN 72 49 15 4 1 3 —
Albany, NY 46 33 9 1 1 2 2 Knoxville, TN 86 51 18 6 1 — 8
Allentown, PA 27 17 9 1 — — — Lexington, KY 113 66 31 8 6 2 6
Buffalo, NY 73 47 19 3 2 2 3 Memphis, TN 174 111 39 12 5 7 19
Camden, NJ 18 13 4 — 1 — 1 Mobile, AL 72 47 20 1 2 2 3
Elizabeth, NJ 19 16 — 2 — 1 1 Montgomery, AL 27 20 5 — 2 — 2
Erie, PA 44 30 6 5 2 1 3 Nashville, TN 147 85 43 9 3 7 14
Jersey City, NJ 26 15 6 2 2 1 2 W.S. Central 1,239 795 310 75 28 31 66
New York City, NY 1,036 718 243 47 18 9 43 Austin, TX 97 61 21 6 2 7 3
Newark, NJ 40 17 17 3 3 — 1 Baton Rouge, LA 69 58 7 3 1 — —
Paterson, NJ 22 7 8 1 1 5 3 Corpus Christi, TX 63 35 15 9 2 2 4
Philadelphia, PA 156 93 47 7 7 2 3 Dallas, TX 189 113 53 10 6 7 7
Pittsburgh, PA§ 27 20 5 2 — — 1 El Paso, TX 52 36 11 2 2 1 1
Reading, PA 32 25 6 1 — — 3 Fort Worth, TX U U U U U U U
Rochester, NY 35 25 8 1 — 1 2 Houston, TX 312 186 91 25 4 6 22
Schenectady, NY 14 11 3 — — — — Little Rock, AR 51 29 15 3 1 3 —
Scranton, PA 28 22 5 1 — — 3 New Orleans, LA U U U U U U U
Syracuse, NY 53 37 10 2 3 1 3 San Antonio, TX 234 159 56 9 8 2 16
Trenton, NJ 18 14 4 — — — 1 Shreveport, LA 43 29 11 1 — 2 2
Utica, NY 12 10 2 — — — 4 Tulsa, OK 129 89 30 7 2 1 11
Yonkers, NY 17 14 3 — — — — Mountain 1,099 694 293 61 22 28 65
E.N. Central 2,014 1,368 451 117 41 37 149 Albuquerque, NM 101 74 21 2 2 2 11
Akron, OH 64 39 17 5 — 3 6 Boise, ID 55 36 11 4 4 — 2
Canton, OH 51 37 10 2 — 2 5 Colorado Springs, CO 67 44 21 1 — 1 2
Chicago, IL 222 144 60 10 5 3 26 Denver, CO 75 45 15 7 1 7 6
Cincinnati, OH 112 59 32 10 4 7 9 Las Vegas, NV 296 201 72 14 5 4 18
Cleveland, OH 253 189 52 8 4 — 8 Ogden, UT 34 20 10 3 — 1 1
Columbus, OH 216 147 50 11 2 6 20 Phoenix, AZ 144 76 46 11 4 7 8
Dayton, OH 145 100 29 12 3 1 7 Pueblo, CO 37 21 12 3 1 — 2
Detroit, MI 109 55 36 13 5 — 3 Salt Lake City, UT 120 75 33 7 1 4 10
Evansville, IN 53 38 11 4 — — 7 Tucson, AZ 170 102 52 9 4 2 5
Fort Wayne, IN 76 57 12 5 1 1 4 Pacific 1,712 1,178 375 91 35 33 162
Gary, IN 15 8 4 2 1 — 1 Berkeley, CA 11 7 3 1 — — 2
Grand Rapids, MI 57 37 11 5 2 2 2 Fresno, CA 122 90 18 10 1 3 21
Indianapolis, IN 222 155 50 8 5 4 20 Glendale, CA 38 33 5 — — — 6
Lansing, MI 44 32 6 5 — 1 4 Honolulu, HI 66 49 8 7 — 2 8
Milwaukee, WI 92 57 24 5 4 2 7 Long Beach, CA 58 35 17 4 — 2 6
Peoria, IL 60 47 9 1 1 2 8 Los Angeles, CA 273 154 77 23 10 9 26
Rockford, IL 42 30 6 3 2 1 5 Pasadena, CA 15 9 3 1 1 1 —
South Bend, IN 34 28 6 — — — 3 Portland, OR 115 87 23 3 1 1 7
Toledo, OH 82 55 19 4 2 2 1 Sacramento, CA 186 128 45 5 4 4 20
Youngstown, OH 65 54 7 4 — — 3 San Diego, CA 190 137 33 8 6 6 20
W.N. Central 652 432 150 39 21 10 53 San Francisco, CA 115 71 33 7 4 — 9
Des Moines, IA 73 49 17 4 1 2 6 San Jose, CA 191 136 41 7 3 4 13
Duluth, MN 39 28 6 3 1 1 1 Santa Cruz, CA 33 17 13 1 2 — 3
Kansas City, KS 33 14 15 3 1 — 3 Seattle, WA 114 82 22 7 3 — 11
Kansas City, MO 119 83 21 6 7 2 17 Spokane, WA 79 61 17 — — 1 6
Lincoln, NE 52 40 10 1 — 1 5 Tacoma, WA 106 82 17 7 — — 4
Minneapolis, MN 62 34 19 5 2 2 4 Total¶ 11,043 7,270 2,649 634 248 230 759
Omaha, NE 107 76 23 5 2 1 6
St. Louis, MO 29 17 9 2 1 — 2
St. Paul, MN 53 39 6 4 3 1 6
Wichita, KS 85 52 24 6 3 — 3
U: Unavailable.   —: No reported cases.   
* Mortality data in this table are voluntarily reported from 122 cities in the United States, most of which have populations of >100,000. A death is reported by the place of its occurrence and 
by the week that the death certificate was filed. Fetal deaths are not included.
† Pneumonia and influenza.
§ Because of changes in reporting methods in this Pennsylvania city, these numbers are partial counts for the current week. Complete counts will be available in 4 to 6 weeks.
¶ Total includes unknown ages.
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